# Chapter 122: Major Neurocognitive Disorder

# The Biological and Neurological Basis of Major Neurocognitive Disorder

## Introduction

Major Neurocognitive Disorder (MND), a term encompassing what was historically known as dementia, represents a clinical syndrome defined by a significant, acquired decline in cognitive functioning from a previous baseline (Taylor & Whitney, 2021; Drake & Casher, 2020; Rucci & Feinstein, 2014). This deterioration is not a feature of normal aging but rather the manifestation of an underlying neuropathological process (Morris & McManus, 1991; Apostolova, 2014). The diagnosis requires evidence of substantial impairment in one or more cognitive domains—such as complex attention, executive function, learning and memory, language, perceptual-motor abilities, and social cognition—that is severe enough to interfere with independence in everyday activities and social or occupational functioning (Taylor & Whitney, 2021; Rucci & Feinstein, 2014; Arenson et al., 2010; Poljak, 2018; American Psychiatric Association, 2000). The onset is typically insidious, and the course is often progressive, distinguishing it from acute and fluctuating states of confusion like delirium, during which a diagnosis of MND cannot be solely made (Arenson et al., 2010; Poljak, 2018; Tang‐Wai et al., 2005; Francis, 1997).

From a biological perspective, MND is not a single disease but a final common pathway for a multitude of brain pathologies (Poljak, 2018; Stahl & Morrissette, 2018). These include neurodegenerative conditions such as Alzheimer's disease (AD), which is the most common cause, frontotemporal lobar degeneration (FTLD), and Lewy body disease, as well as vascular disease, traumatic brain injury (TBI), infections, and metabolic disturbances (Poljak, 2018; Stahl & Morrissette, 2018; Knopman, 2017; Ousset, 1998). While clinical presentations vary depending on the underlying etiology, they all reflect a fundamental disruption of cerebral structure and function (Weller et al., 1983). The progressive loss of neurons and synaptic connections, coupled with the accumulation of pathological proteins, leads to the unravelling of the complex neural circuits that subserve higher mental functions (Love & Geldmacher, 2018; Kumar & Bansal, 2021).

Understanding the biological and neurological basis of MND is critical for several reasons. It informs differential diagnosis, allowing clinicians to distinguish between various etiologies that may have different prognoses and management strategies (Knopman, 2017; Sellal et al., 2004). It provides targets for pharmacological and non-pharmacological interventions aimed at slowing disease progression or alleviating symptoms (Dickerson & Sperling, 2007; Rucci & Feinstein, 2014). Furthermore, elucidating these mechanisms is essential for identifying biomarkers for early detection, often at the preclinical or Mild Cognitive Impairment (MCI) stage, which is considered a transitional state between normal aging and dementia (Petersen, 2004; Johnson, 2009; Domoto‐Reilly et al., 2014). This chapter will provide a comprehensive overview of the current understanding of the biological and neurological foundations of Major Neurocognitive Disorder, synthesizing evidence from neuroimaging, genetics, cellular biology, and neuropharmacology to construct a holistic picture of this complex and devastating syndrome.

## Neurobiological Systems

The cognitive and behavioral manifestations of Major Neurocognitive Disorder (MND) are rooted in the progressive dysfunction of specific neurobiological systems. These systems, encompassing neurotransmitter pathways, large-scale neural networks, and fundamental processes like sleep regulation, are disrupted by the underlying pathology, leading to the clinical syndrome.

### Neurotransmitter Systems and Neuropharmacology

Dysregulation of key neurotransmitter systems is a central feature in many forms of MND, providing the rationale for current symptomatic treatments (Rucci & Feinstein, 2014; Spiegel, 2002). The cholinergic system, in particular, has been a major focus. A deficiency in acetylcholine transmission is a validated etiopathogenic hypothesis in Alzheimer's disease (AD), stemming from the degeneration of cholinergic neurons in structures like the nucleus basalis of Meynert (Spiegel, 2002; Cristina et al., 2019; Hornykiewicz & Kish, 1984). This cholinergic deficit contributes significantly to impairments in memory and attention (Spiegel, 2002; Wu et al., 2007). Pharmacological interventions, such as acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine), aim to enhance cholinergic neurotransmission by reducing the breakdown of acetylcholine in the synapse, thereby offering modest symptomatic relief and stabilization of cognitive function (Rucci & Feinstein, 2014; Spiegel, 2002; Budson & Kensinger, 2023; Malek & Greene, 2014). However, these agents may also have cognitive side effects that can complicate assessment (Mula & Trimble, 2006).

The glutamatergic system, the primary excitatory network in the brain, is also critically implicated. In AD, hyperactivity of N-methyl-D-aspartate (NMDA) receptors is thought to contribute to excitotoxicity and subsequent neuronal death (Cristina et al., 2019; Kumar & Bansal, 2021). The NMDA receptor antagonist memantine is used in moderate to severe AD to modulate this glutamatergic overactivity, potentially protecting neurons from further damage and providing symptomatic benefits, sometimes in combination with cholinesterase inhibitors (Rucci & Feinstein, 2014; Allan et al., 2013). Glutamatergic dysfunction is also hypothesized to play a role in the cognitive deficits seen in schizophrenia, a disorder with significant neurocognitive overlap with some dementias (Gorgievski, 2013; Jones, 2010).

Dopaminergic pathways are also profoundly affected, particularly in MND associated with parkinsonism, such as Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) (Schmidt, 2005; Hornykiewicz & Kish, 1984). The degeneration of dopaminergic neurons in the substantia nigra is the hallmark of Parkinson's disease (PD), leading to motor symptoms, but depletion in the mesocortico-limbic dopamine system also contributes to cognitive and motivational deficits, including apathy and executive dysfunction (Schmidt, 2005; Szirmai & Kovács, 2002; Martínez‐Castrillo et al., 2011). While levodopa and dopamine agonists can alleviate motor symptoms, their effect on cognition is variable, and they can sometimes induce or exacerbate psychiatric symptoms like hallucinations and psychosis, which are common in these disorders (Martínez‐Castrillo et al., 2011; Poewe & Luginger, 1999). Indeed, dopaminergic hyperactivity has been linked to psychotic symptoms in schizophrenia, highlighting the delicate balance required for normal cognitive and behavioral function (Freedman et al., 1987; Sumiyoshi, 2008).

Other monoaminergic systems, including the serotonergic and noradrenergic pathways, are also disrupted in MND. Degeneration of the locus coeruleus (noradrenergic) and dorsal raphe nuclei (serotonergic) is observed in both AD and PD, contributing to non-motor symptoms like depression, anxiety, and sleep disturbances (Szirmai & Kovács, 2002; Hornykiewicz & Kish, 1984). Serotonin dysfunction, in particular, is implicated in mood disorders and impulsivity, which are frequent comorbidities in dementia (Sumiyoshi, 2008; Greden, 2003; Evenden, 1999). Consequently, selective serotonin reuptake inhibitors (SSRIs) are often used to manage these neuropsychiatric symptoms (Tune, 1998; Poewe & Luginger, 1999), although their impact on core cognitive deficits is limited (Hindmarch, 1998). The gamma-aminobutyric acid (GABA) system, the brain's primary inhibitory network, is also involved. An imbalance between excitatory glutamatergic and inhibitory GABAergic signaling is thought to contribute to cognitive deficits in conditions like schizophrenia and autism spectrum disorders (Sesarini, 2015; Jones, 2010). Furthermore, many sedative-hypnotic medications used to manage insomnia or agitation in dementia, such as benzodiazepines, act on GABA-A receptors, which can paradoxically worsen cognitive function and increase fall risk (Wilson & Nutt, 2013; Budson & Kensinger, 2023).

### Sleep, Arousal, and Circadian Systems

Sleep disturbances are a near-universal feature of MND and are bidirectionally linked with cognitive decline (Miller, 2015; Chiba & Tamura, 2015). Patients commonly experience insomnia, characterized by difficulty initiating or maintaining sleep, frequent awakenings, and nonrestorative sleep (Lee‐Chiong, 2008; Bonnet & Arand, 2008; Schenck, 2003). These issues are often compounded by a disturbed sleep-wake cycle, sometimes with a complete reversal of the normal rhythm (Lee‐Chiong, 2008; Chiba & Tamura, 2015; Krystal et al., 2013). The neuropathological processes in dementia directly impact brain regions crucial for sleep regulation, including the hypothalamic suprachiasmatic nucleus, which governs circadian rhythms (Heß, 1997; Bassetti, 2001).

The consequences of poor sleep are significant, leading to daytime fatigue, impaired concentration, memory problems, and mood disturbances like irritability and anxiety, which can exacerbate the core cognitive and behavioral symptoms of dementia (Schenck, 2003; Doghramji, 2003; Riemann et al., 2022). Chronic sleep loss is a major risk factor for accidents and functional decline (Schenck, 2003; Krystal et al., 2013). From a neurobiological standpoint, sleep is critical for memory consolidation and the clearance of neurotoxic proteins like amyloid-β (Akter et al., 2021; Chauhan et al., 2021). Thus, disrupted sleep may not only be a symptom of neurodegeneration but may also actively contribute to its progression, creating a vicious cycle (Miller, 2015; Chauhan et al., 2021).

Specific sleep disorders are also highly prevalent in populations with MND. Obstructive sleep apnea (OSA), characterized by repetitive airway obstruction during sleep, is common in older adults and is an independent risk factor for cognitive impairment and dementia (Miller, 2015; Bilyukov et al., 2018; Guilleminault et al., 1992). The intermittent hypoxia associated with OSA is believed to contribute to hippocampal damage and cognitive deficits, particularly in attention and executive function (Feng et al., 2012; Verstraeten et al., 1996). Other conditions like REM sleep behavior disorder (RBD), where patients physically act out their dreams, are hallmark features of synucleinopathies like DLB and PD and can be a very early, even prodromal, sign of these diseases (Blanc & Verny, 2017; Derouesné, 2006; Tachibana et al., 1997). The management of sleep disturbances is a critical, albeit challenging, aspect of dementia care, often starting with non-pharmacological approaches like improving sleep hygiene before considering medications, which carry their own risks of cognitive side effects (Lee‐Chiong, 2008; Krystal et al., 2013).

## Genetic and Molecular Basis

Major Neurocognitive Disorder is increasingly understood as the clinical outcome of complex interactions between genetic predispositions and environmental or molecular triggers. While most cases of late-onset dementia are sporadic, a significant minority have a clear genetic basis, and heritable factors play a substantial role in determining an individual's lifetime risk (Kumar & Bansal, 2021; Meehl, 1989).

### Genetic Factors and Heritability

The heritability of neurodegenerative diseases varies. For instance, a positive family history is a known risk factor for Alzheimer's disease (AD), suggesting a genetic component (Allan et al., 2013). Rare, autosomal dominant mutations in genes such as *APP*, *PSEN1*, and *PSEN2* cause early-onset familial AD, although these account for a very small fraction of all cases (Mendez, 2006). For the more common late-onset AD, the apolipoprotein E (ApoE) gene is the most significant known genetic risk factor (Willroth et al., 2022). The ε4 allele of the ApoE gene increases the risk and lowers the age of onset for AD, likely through its role in amyloid-β (Aβ) aggregation and clearance (Jellinger, 2000; Tardiff et al., 2004).

Other neurodegenerative disorders also have strong genetic underpinnings. Huntington's disease is an autosomal dominant disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene (Brandt & Butters, 1996). Certain forms of frontotemporal lobar degeneration (FTLD) are caused by mutations in genes such as *MAPT* (tau), *GRN* (progranulin), and *C9ORF72* (Knopman, 2017). Genetic factors are also implicated in Parkinson's disease (PD), with mutations in genes like *α-synuclein* and *Parkin* being linked to familial forms of the disease, although these typically do not present with cognitive impairment initially (Jellinger, 2000; Barker & Redfern, 2019). The concept of a "schizogene" has been proposed for schizophrenia, a disorder with substantial cognitive deficits, suggesting a dominant gene may confer a neural integrative defect termed schizotaxia (Meehl, 1989). Furthermore, a variety of rare genetic syndromes and chromosomal abnormalities, such as 22q11.2 deletion syndrome, Down syndrome, and Fragile X syndrome, are associated with both intellectual disability and an increased risk of later-life cognitive decline or specific dementia pathologies (Tang et al., 2015; Grieco et al., 2015; Gonçalves et al., 2007; Moser, 1989).

### Molecular Mechanisms

At the molecular level, the defining feature of most neurodegenerative dementias is the abnormal aggregation and deposition of misfolded proteins in the brain (Kumar & Bansal, 2021). In AD, the two core pathologies are extracellular plaques composed of Aβ peptides and intracellular neurofibrillary tangles (NFTs) made of hyperphosphorylated tau protein (Wierenga & Bondi, 2011; Love & Geldmacher, 2018). The "amyloid cascade hypothesis" posits that the accumulation of Aβ is the primary event that triggers a downstream cascade of tau pathology, synaptic dysfunction, neuroinflammation, and eventual neuronal death (Wierenga & Bondi, 2011; Kumar & Bansal, 2021). Biomarkers reflecting these processes, such as low Aβ42 and high tau/phosphorylated tau in the cerebrospinal fluid (CSF) or positive amyloid PET imaging, are now used to support a diagnosis of AD, even in the mild cognitive impairment (MCI) stage (Suzuki, 2012; Hanyu, 2011).

In contrast, a group of disorders known as synucleinopathies, which includes PD, dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), are characterized by the aggregation of α-synuclein protein into Lewy bodies and Lewy neurites (Jellinger, 2000; Szirmai & Kovács, 2002). The distribution of this pathology dictates the clinical syndrome; in DLB, Lewy bodies are widespread in cortical and limbic regions, correlating with cognitive and psychiatric symptoms, whereas in PD, the pathology typically begins in the brainstem and ascends, with cortical involvement occurring later in the disease course (Jellinger, 2000; Hornykiewicz & Kish, 1984).

The frontotemporal lobar degenerations (FTLD) are pathologically heterogeneous and are broadly classified by the primary protein aggregate, which can be tau (FTLD-tau), TAR DNA-binding protein 43 (TDP-43), or Fused in Sarcoma (FUS) (Kerchner & Rosenbloom, 2014; Knopman, 2017). These different molecular subtypes often correspond to distinct clinical syndromes, though the relationship is not absolute (Kerchner & Rosenbloom, 2014).

Beyond proteinopathy, a host of other molecular pathways are implicated in the neurodegenerative process. Neuroinflammation, involving the activation of microglia and astrocytes and the release of pro-inflammatory cytokines, is a common feature across many dementias and is thought to both respond to and exacerbate neuronal damage (Carvalho et al., 2015; Borlongan et al., 2016; Jones, 2010). Oxidative stress, resulting from an imbalance between the production of reactive oxygen species and the brain's antioxidant defenses, is another key mechanism contributing to neuronal injury (Carvalho et al., 2015; Hamed, 2014). Mitochondrial dysfunction, leading to deficits in cellular energy production, is also widely implicated, particularly in PD and AD (Carvalho et al., 2015; Hamed, 2014). Furthermore, disruptions in synaptic function and plasticity are considered early events in the pathogenic cascade, preceding overt neuronal loss and contributing directly to cognitive symptoms (Kumar & Bansal, 2021; Kopach & Pivneva, 2018). These interconnected molecular pathways highlight the multifaceted nature of neurodegeneration and offer a range of potential targets for future disease-modifying therapies (Carvalho et al., 2015; Cummings & Zhong, 2017).

## Brain Structure and Function

Major Neurocognitive Disorder arises from tangible changes in the brain's structure and its functional dynamics. Advances in neuroimaging and neuropsychology have provided unprecedented windows into these alterations, linking specific patterns of brain pathology to the diverse clinical syndromes observed in patients (Tranel et al., 2003; Savage, 2010).

### Neuroimaging Findings: Structural and Functional

Neuroimaging is indispensable for the diagnostic work-up of dementia, serving to exclude other pathologies (e.g., tumors, subdural hematomas) and to identify patterns of atrophy or functional change that can support a specific etiological diagnosis (Dickerson & Sperling, 2007; Allan et al., 2013). Structural Magnetic Resonance Imaging (MRI) is a cornerstone of this evaluation. In Alzheimer's disease (AD), MRI typically reveals atrophy that is most prominent in medial temporal lobe structures, particularly the hippocampus and entorhinal cortex, which aligns with the early and profound episodic memory deficits characteristic of the disease (Love & Geldmacher, 2018; Wierenga & Bondi, 2011; Butters et al., 1996). As the disease progresses, atrophy spreads to temporo-parietal association cortices (Dickerson & Sperling, 2007; Suzuki, 2012). In contrast, behavioral variant frontotemporal dementia (bvFTD) is associated with disproportionate atrophy in frontal and/or anterior temporal lobes, correlating with the observed changes in personality, social conduct, and executive function (Kerchner & Rosenbloom, 2014; Shany‐Ur & Rankin, 2011). Asymmetric atrophy of the left temporal pole is a hallmark of semantic dementia (Boeve, 2004; Donoso et al., 2008), while left perisylvian atrophy is seen in progressive nonfluent aphasia (Kerchner & Rosenbloom, 2014). Vascular dementia (VaD) is characterized by evidence of cerebrovascular disease, such as cortical or subcortical infarcts, or extensive white matter hyperintensities (leukoaraiosis), which disrupt cortical-subcortical circuits (Sellal et al., 2004; Szirmai & Kovács, 2002).

Functional neuroimaging techniques, such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT), provide complementary information by measuring regional cerebral blood flow or metabolism. In AD, a characteristic pattern of bilateral temporo-parietal hypometabolism or hypoperfusion is often observed (Dickerson & Sperling, 2007; Suzuki, 2012). This pattern can help differentiate AD from other dementias; for example, FTD often shows frontal hypometabolism, while dementia with Lewy bodies (DLB) may present with occipital hypoperfusion (Dickerson & Sperling, 2007; Derouesné, 2006). More recently, amyloid PET imaging has enabled the in-vivo detection of amyloid plaques, a core pathology of AD, increasing diagnostic certainty, particularly in atypical cases (Suzuki, 2012; Garrett et al., 2011).

### Brain Regions, Neural Circuits, and Functional Connectivity

The cognitive and behavioral deficits in MND are not simply due to focal lesions but result from the disruption of large-scale, distributed neural networks (Tranel et al., 2003; Jones, 2010). Cognitive functions like memory, attention, and executive control are emergent properties of the coordinated activity within and between brain regions (Sandi, 2013; Barch, 2003).

The prefrontal cortex (PFC) and its extensive connections are critical for executive functions, including planning, decision-making, working memory, and behavioral inhibition (Sun, 2018; Wheeler, 2014; Sandi, 2013). Dysfunction in fronto-striatal circuits, involving the PFC and basal ganglia, underlies the executive deficits seen in a wide range of disorders, including PD, Huntington's disease, VaD, and FTD (Cummings & Benson, 1988; Jankowicz et al., 1998; Sellal et al., 2004). This fronto-subcortical dysfunction is also implicated in apathy, a common and disabling symptom across many dementias (Godefroy et al., 2016; Martínez‐Horta et al., 2013).

The medial temporal lobes, especially the hippocampus, are central to episodic memory—the ability to learn and recall new personal experiences (Budson, 2014; DeJong, 1969). The selective vulnerability of these structures in early AD explains why episodic memory impairment is the cardinal feature of the disease (Love & Geldmacher, 2018; Butters et al., 1996; Hodges & Graham, 2002). In contrast, semantic memory, our knowledge of facts and concepts, relies more on the anterior and lateral temporal cortices, which are the primary sites of atrophy in semantic dementia (Boeve, 2004; Hodges & Graham, 2002).

Language functions are subserved by a complex left-hemisphere network. Damage to different nodes of this network results in different types of aphasia, as seen in primary progressive aphasia (PPA) syndromes (Mesulam, 2013; Boeve, 2004). The nonfluent/agrammatic variant of PPA is linked to dysfunction in the left fronto-insular region, whereas the logopenic variant involves the left temporo-parietal junction (Mesulam, 2013; Torres Urazán et al., 2023).

Functional connectivity studies, using techniques like resting-state fMRI, examine the temporal correlation of activity between different brain regions, providing insights into the integrity of these large-scale networks. In AD, a common finding is reduced connectivity within the default mode network (DMN), a set of brain regions including the posterior cingulate/precuneus and medial temporal lobes that is active during rest and implicated in autobiographical memory and self-referential thought (Jiménez-Marín et al., 2018). Disruption of other networks, such as the salience and executive control networks, is also observed and correlates with attentional and executive deficits (Faustino, 2021). The concept of dementia as a "disconnection syndrome," where pathology disrupts the communication between brain regions, is a powerful framework for understanding the widespread cognitive consequences of neurodegenerative disease (Jones, 2010; van Dellen et al., 2014).

## Developmental Neurobiology

Major Neurocognitive Disorder is fundamentally a condition of brain aging, but its roots and trajectory are deeply influenced by developmental processes across the entire lifespan. The brain's structural and functional organization is not static; it is shaped by a lifelong interplay between genetic programming and environmental experience (Rothenberger & Hüther, 1997). This perspective is crucial for understanding individual differences in vulnerability, the timing of symptom onset, and the clinical expression of MND.

### Developmental Trajectories and Critical Periods

Neurodevelopmental disorders, such as intellectual disability, autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD), provide a window into how early brain development can influence later-life cognitive outcomes (Patel & Merrick, 2020; Gillberg & Minnis, 2013). These conditions are characterized by impairments in cognitive, motor, or social functions with onset during the developmental period (Patel & Merrick, 2020; Dziegielewski, 2014). While distinct from acquired MNDs, they highlight the concept of "neurodevelopmental vulnerability." For instance, individuals with Down syndrome have a near-universal risk of developing Alzheimer's disease pathology by middle age, demonstrating how a specific genetic abnormality can set the stage for later neurodegeneration (Grieco et al., 2015; Cooper & Prasher, 1998). Similarly, other genetic syndromes are associated with an increased risk for specific psychiatric and cognitive profiles that may evolve over time (Tang et al., 2015).

The concept of critical or sensitive periods in development, during which the brain is particularly susceptible to environmental influences, is highly relevant (Deonna, 2010). Early life adversity, such as psychosocial stress or trauma, can alter the maturation of stress-response systems like the hypothalamic-pituitary-adrenal (HPA) axis and impact the development of brain structures critical for cognition and emotion, such as the prefrontal cortex and hippocampus (Rothenberger & Hüther, 1997; Kavanaugh et al., 2016). Such early experiences may contribute to what has been termed "cognitive reserve"—the brain's ability to withstand neuropathology without showing clinical symptoms (Barnett et al., 2006; Vance, 2012). A richer cognitive reserve, often associated with factors like higher education and occupational complexity, may delay the clinical onset of dementia by providing a buffer against underlying brain changes (Barnett et al., 2006; Lara, 2017).

### Prodromal States and Early Detection

Neurodegenerative diseases do not appear suddenly; they have long preclinical and prodromal phases during which pathology accumulates in the brain before the full criteria for MND are met (Wierenga & Bondi, 2011; Dushanova, 2017). The concept of Mild Cognitive Impairment (MCI) was developed to characterize this transitional state (Petersen, 2004; Johnson, 2009). MCI is defined by an acquired, objective cognitive decline that is greater than expected for age but does not yet significantly interfere with independent daily functioning (Petersen, 2004; Radanovic et al., 2015; Johnson, 2009). Individuals with MCI are at a significantly elevated risk of progressing to dementia, making this syndrome a critical target for early diagnosis and intervention (Bozoki et al., 2001; Domoto‐Reilly et al., 2014).

The clinical presentation of MCI is heterogeneous. Amnestic MCI (aMCI), characterized by a primary memory impairment, is the most common subtype and is often a precursor to AD (Petersen, 2004; Rozzini et al., 2007). However, non-amnestic forms of MCI also exist, where deficits in other domains like executive function or language are more prominent (Petersen, 2004; Rozzini et al., 2007). These may be prodromal stages of other dementias, such as FTD or DLB (Domoto‐Reilly et al., 2014; Blanc & Verny, 2017). The emergence of specific behavioral changes, such as apathy or disinhibition, in the context of mild cognitive symptoms may represent a "mild behavioral impairment" (MBI) and can also be a harbinger of FTLD (Schölzel-Dorenbos, 2006).

Even before the stage of MCI, individuals may experience subjective cognitive decline (SCD), where they perceive a worsening of their cognitive abilities, particularly memory, despite performing within the normal range on standard neuropsychological tests (Kuiper, 2016; Basagni & Navarrete, 2025). While SCD can be associated with non-neurodegenerative factors like depression or anxiety (Mah et al., 2021; Iliffe & Pealing, 2010), a subset of individuals with SCD, particularly those who are worried about their decline, show a higher risk of future objective cognitive decline and dementia (Mah et al., 2021). These very early stages represent a critical window of opportunity for preventive strategies, as interventions are likely to be most effective before substantial and irreversible neuronal loss has occurred (Behrman & Ebmeier, 2014; Allan et al., 2013). The challenge for clinicians and researchers is to differentiate benign, age-related complaints from the first subtle signs of a progressive neurodegenerative process (Charante et al., 2022; Iliffe & Pealing, 2010).

## Treatment Mechanisms

Currently, there are no curative treatments for the most common neurodegenerative causes of Major Neurocognitive Disorder. The therapeutic landscape is primarily focused on symptomatic management, aiming to temporarily improve cognitive function, manage behavioral and psychological symptoms (BPSD), and maintain functional independence for as long as possible (Dickerson & Sperling, 2007; Kumar & Bansal, 2021). The biological basis of these interventions targets the neurotransmitter systems and molecular pathways known to be disrupted by the underlying disease.

### Pharmacological Interventions

The mainstay of pharmacological treatment for Alzheimer's disease (AD) targets the profound cholinergic deficit that characterizes the condition (Spiegel, 2002; Wu et al., 2007). Acetylcholinesterase inhibitors (AChEIs), including donepezil, rivastigmine, and galantamine, work by increasing the synaptic availability of acetylcholine (Rucci & Feinstein, 2014). By inhibiting the enzyme that breaks down acetylcholine, these drugs enhance cholinergic neurotransmission, which is crucial for memory and attention (Spiegel, 2002; Allan et al., 2013). Clinical trials have demonstrated that AChEIs can produce modest, short-term stabilization of cognitive function and activities of daily living (ADLs) in patients with mild to moderate AD (Dickerson & Sperling, 2007; Spiegel, 2002). Rivastigmine has also shown efficacy in Parkinson's disease dementia (PDD) (Paulig, 2006; Kavanagh & Marder, 2012).

A second major pharmacological strategy targets the glutamatergic system. Excitotoxicity, caused by excessive stimulation of NMDA receptors by glutamate, is believed to contribute to neuronal death in AD (Cristina et al., 2019). Memantine, a non-competitive NMDA receptor antagonist, is thought to be neuroprotective by reducing this pathological glutamatergic activity (Rucci & Feinstein, 2014; Kumar & Bansal, 2021). It is approved for moderate to severe AD and may be more effective when used in combination with an AChEI (Rucci & Feinstein, 2014).

The management of BPSD often involves the off-label use of psychotropic medications developed for other psychiatric disorders (Stahl & Morrissette, 2018; Ballard et al., 2001). Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are frequently used to treat depression and anxiety in dementia (Poewe & Luginger, 1999; Tune, 1998). Atypical antipsychotics like risperidone are sometimes used for agitation, aggression, and psychosis, though their use is limited by modest efficacy and significant safety concerns, including an increased risk of stroke and mortality (Stahl & Morrissette, 2018; Malenfant et al., 2008). Patients with dementia with Lewy bodies (DLB) are particularly vulnerable to severe adverse reactions from neuroleptics, highlighting the need for cautious and precise diagnosis (Derouesné, 2006).

Emerging pharmacological strategies are aimed at being "disease-modifying" by targeting the core molecular pathologies. A significant focus has been on therapies targeting amyloid-β (Aβ), such as monoclonal antibodies designed to clear Aβ plaques from the brain, though clinical trial results have been mixed (Suzuki, 2012). Other investigational approaches target tau pathology, neuroinflammation, and synaptic plasticity (Carvalho et al., 2015; Sun, 2018). Cognitive enhancers, or nootropics, originally developed for conditions like ADHD, are also being explored for their potential to improve attention and executive function in dementia, but evidence remains limited (Buitelaar, 2003; Outhoff, 2016).

### Non-Pharmacological and Rehabilitative Approaches

Non-pharmacological interventions are a cornerstone of dementia care, aiming to improve quality of life and manage symptoms with fewer side effects than medication (Sung & Chang, 2010; Ibrahim et al., 2017). Cognitive rehabilitation and cognitive stimulation are structured activities designed to maintain or improve cognitive function (Turi et al., 2024; Bird, 2000). These interventions are based on the principle of neuroplasticity—the brain's ability to reorganize itself by forming new neural connections (Vance, 2012). Cognitive training may involve computerized exercises targeting specific domains like attention or working memory, and has shown some promise in improving performance on trained tasks (Medalia & Lim, 2004; Cheng et al., 2024). The biological mechanisms may involve enhancing neural efficiency or recruiting compensatory brain regions (Marušič & Grosprêtre, 2018).

Physical exercise is another promising intervention with a strong biological rationale (Behrman & Ebmeier, 2014; Manning & Wolfson, 2017). Regular physical activity has been shown to improve cerebral blood flow, promote neurogenesis (the birth of new neurons), and increase levels of neurotrophic factors like brain-derived neurotrophic factor (BDNF), which supports neuronal survival and growth (Sun, 2018; Peven et al., 2019). These effects may help to bolster cognitive reserve and slow the rate of cognitive decline in older adults and those with dementia (Behrman & Ebmeier, 2014; Peven et al., 2019).

Environmental modifications and behavioral strategies are crucial for managing BPSD and supporting functional independence (Ibrahim et al., 2017; Guaita, 2011). This "prosthetic" approach aims to compensate for cognitive deficits by simplifying the environment, establishing predictable routines, and using external aids like calendars and reminders (Guaita, 2011; Bird, 2000). Music therapy, particularly using familiar or preferred music, has been shown to reduce agitation and anxiety, possibly by activating preserved emotional memory networks and providing a soothing, familiar stimulus (Sung & Chang, 2010; Natividad, 2020). Ultimately, the most effective treatment plans integrate pharmacological and non-pharmacological approaches in a personalized manner, adapting to the patient's changing needs throughout the course of the disease (Ibrahim et al., 2017).

## Future Directions

The field of Major Neurocognitive Disorder is at a critical juncture, moving from a focus on late-stage symptomatic management towards early detection and disease modification. While significant challenges remain, emerging research in neurobiology, technology, and therapeutics is paving the way for a new era in understanding and treating these devastating conditions.

One of the most pressing priorities is the development of effective disease-modifying therapies (Dickerson & Sperling, 2007; Kumar & Bansal, 2021). The limited success of anti-amyloid treatments in late-stage Alzheimer's disease (AD) has shifted focus towards earlier intervention, targeting individuals in the preclinical or prodromal stages of the disease (Suzuki, 2012; Allan et al., 2013). This requires more sensitive and specific biomarkers to accurately identify individuals at risk long before significant cognitive decline is apparent (Garrett et al., 2011). Future research will likely integrate fluid biomarkers (e.g., from CSF or blood) with advanced neuroimaging to create comprehensive risk profiles and track pathological progression (Suzuki, 2012; Arnaldi et al., 2012). The development of novel PET tracers for tau pathology, neuroinflammation, and synaptic density will provide a more complete in-vivo picture of the disease process, moving beyond amyloid alone (Carvalho et al., 2015; Jones, 2010).

Beyond the amyloid-tau-neurodegeneration model of AD, research is expanding to explore a wider range of pathogenic mechanisms that may serve as novel therapeutic targets (Carvalho et al., 2015). These include targeting neuroinflammation, oxidative stress, mitochondrial dysfunction, and vascular contributions to neurodegeneration (Carvalho et al., 2015; Hamed, 2014; Kumar & Bansal, 2021). A "multitargeting" approach, using agents that act on multiple pathways simultaneously, may prove more effective than single-target drugs, reflecting the complex, multifactorial nature of MND (Tomasetti, 2014). The potential for neurotrophic factors and agents that promote neuroplasticity and synaptic health represents another promising avenue for restorative, rather than just protective, therapies (Sun, 2018; Previgliano et al., 2015).

Improving the treatment of cognitive and behavioral symptoms remains a key goal. There is a significant need for genuinely novel "cognitive enhancers" that can improve domains like executive function, attention, and processing speed, which are poorly addressed by current medications (Cummings & Zhong, 2017; Buitelaar, 2003). Understanding the shared neurobiological underpinnings of cognitive deficits across different psychiatric and neurological disorders may allow for the development of transdiagnostic treatments (Goschke, 2013; Ramey & Regier, 2018). Non-invasive brain stimulation techniques, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), are being explored for their potential to modulate neural circuit activity and enhance cognitive function, offering a non-pharmacological alternative with potentially fewer systemic side effects (Kar & Singh, 2022; Lara-Plaza et al., 2022).

The integration of technology into dementia care is another rapidly advancing frontier. Smart technologies and sensor networks can be used for unobtrusive monitoring of daily activities, sleep patterns, and safety, allowing for earlier detection of functional decline and enabling older adults to remain independent for longer (Yang, 2004; David, 2025). Digital health applications, including computerized cognitive training programs and serious games, offer scalable and accessible methods for cognitive stimulation and rehabilitation (David, 2025; Kerber et al., 2021).

Finally, a greater understanding of the heterogeneity of MND is crucial. Future research must move beyond a "one-size-fits-all" approach and focus on identifying biological subtypes of disorders like AD, which may have different underlying mechanisms and respond differently to treatment (Jellinger, 2000). This requires large-scale, longitudinal cohort studies that combine deep clinical phenotyping with multi-modal biomarkers (genetics, imaging, fluid assays) to unravel the complex pathways leading to cognitive decline (Fowler et al., 2011; Shigematsu et al., 2019). By understanding this heterogeneity, the field can move towards a future of personalized medicine, where interventions are tailored to the specific biological profile of each individual patient (Cummings & Zhong, 2017).

## Conclusion

Major Neurocognitive Disorder represents a final common clinical pathway for a diverse array of underlying neuropathologies, all of which converge to produce a devastating decline in cognitive and functional abilities (Taylor & Whitney, 2021; Arenson et al., 2010). This chapter has synthesized the current understanding of the biological and neurological basis of this syndrome, drawing upon a wide range of research. The evidence clearly indicates that MND is not a simple consequence of aging but a complex disease process involving a cascade of molecular, cellular, and systems-level failures within the brain (Morris & McManus, 1991).

The core of MND pathophysiology lies in the disruption of neural circuits essential for higher cognition. This disruption is driven by a confluence of factors, including the aggregation of pathological proteins like amyloid-β, tau, and α-synuclein, which trigger neuroinflammation, oxidative stress, and synaptic dysfunction, ultimately leading to widespread neuronal loss and brain atrophy (Kumar & Bansal, 2021; Carvalho et al., 2015; Jellinger, 2000). These structural changes are mirrored by functional alterations in key neurotransmitter systems—notably the cholinergic, glutamatergic, and dopaminergic pathways—which form the basis for current symptomatic pharmacotherapies (Rucci & Feinstein, 2014; Spiegel, 2002).

Furthermore, the integrity of fundamental brain processes, such as sleep and circadian regulation, is profoundly compromised in MND. This disruption not only manifests as distressing clinical symptoms like insomnia and daytime sleepiness but may also accelerate the neurodegenerative process itself, creating a pernicious feedback loop (Miller, 2015; Chauhan et al., 2021). The clinical presentation of MND is shaped by the specific topography of brain pathology, resulting in distinct cognitive and behavioral profiles. Whether the initial and most prominent deficits are in episodic memory (as in typical Alzheimer's disease), executive function and social cognition (as in frontotemporal dementia), or attention and visuospatial skills (as in dementia with Lewy bodies), the pattern of impairment reflects the selective vulnerability of specific large-scale neural networks (Love & Geldmacher, 2018; Kerchner & Rosenbloom, 2014; Knopman, 2017).

The long developmental trajectory of these disorders, with preclinical and prodromal phases that can span years or decades, underscores the critical importance of early detection and intervention (Wierenga & Bondi, 2011; Domoto‐Reilly et al., 2014). Identifying individuals in the early stages, such as Mild Cognitive Impairment, offers the best opportunity to deploy strategies—both pharmacological and non-pharmacological—that might slow or prevent the progression to full-blown dementia (Allan et al., 2013). While disease-modifying treatments remain an elusive goal, the ongoing exploration of novel therapeutic targets, combined with advances in cognitive rehabilitation, physical exercise, and technology-based support, offers hope for the future. A comprehensive, biologically informed, and multidisciplinary approach is essential to mitigate the profound personal and societal impact of Major Neurocognitive Disorder.

## References

1. Abascal, R. V., & Romero, L. C. (2012). Disfunción ejecutiva: Síntomas y relevancia de su detección desde Atención Primaria. Revista Clínica de Medicina de Familia. https://doi.org/10.4321/s1699-695x2012000300007
2. Abdelsayed, S., Acevedo, R., & Clemow, L. (2017). Is sleep deprivation associated with behavioral changes in children and adolescents?. Evidence-Based Practice. https://doi.org/10.1097/01.ebp.0000541629.93211.cb
3. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
4. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
5. Agrawal, A., Rahman, M. M., Khan, R. A., Lozada-Martínez, I. D., Moscote‐Salazar, L. R., Mishra, R., & Rahman, S. (2021). FOUR Score or GCS in Neurocritical Care: Modification or Adaptation. Indian Journal of Neurotrauma. https://doi.org/10.1055/s-0041-1732790
6. Akter, R., Kaushik, D., Kumar, K., & Rahman, M. H. (2021). Behavioral Pathophysiology and Psychological Implications for Sleep Disorder in Dementia. https://doi.org/10.1007/978-981-16-4558-7_1
7. Akwa, Y., Allain, H., Lacomblez, L., Lieury, A., & Bentué‐Ferrer, D. (2007). Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/nedt.2007.3.1.103
8. Alalet, R. (2018). Reading Disability: Current Practices for Learning. International Journal of Autism & Related Disabilities. https://doi.org/10.29011/2642-3227.000014
9. Alarcón, V. A. G. (2010). Niños inteligentes que no progresan. Niños desatentos. Revista internacional de investigación en ciencias sociales.
10. Alexander, J. L., Sommer, B., Dennerstein, L., Grigorova, M., Neylan, T. C., Kotz, K., Richardson, G., & Rosenbaum, R. (2007). Role of psychiatric comorbidity on cognitive function during and after the menopausal transition. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.11s.s157
11. Aligeti, S., Baig, M. R., & Barrera, F. F. (2015). Terminal delirium misdiagnosed as major psychiatric disorder: Palliative care in a psychiatric inpatient unit. Palliative & Supportive Care. https://doi.org/10.1017/s147895151500098x
12. Allan, C. L., Behrman, S., & Ebmeier, K. P. (2013). Early diagnosis beneficial in Alzheimer's disease.. PubMed.
13. Allende-Rayme, F. R., Acuña-Vila, J. H., Quezada, J. C. R., & Correa-López, L. E. (2021). Lifestyle Medicine and Sleep Quality in Medical Students. Revista de la Facultad de Medicina Humana. https://doi.org/10.25176/rfmh.v21i2.3716
14. Alluri, P. R., Solit, J., Leveroni, C. L., Goldberg, K. J., Vehar, J. V., Pollak, L., Colvin, M. K., & Perez, D. L. (2020). Cognitive Complaints in Motor Functional Neurological (Conversion) Disorders: A Focused Review and Clinical Perspective. Cognitive and Behavioral Neurology. https://doi.org/10.1097/wnn.0000000000000218
15. Almeida, O. P., Flicker, L., & Lautenschlager, N. T. (2005). Uncommon causes of dementia: rare, but not marginal. International Psychogeriatrics. https://doi.org/10.1017/s1041610205001742
16. Ambali, A. P., & Kumar, P. (2020). Clinical Approach to “I am Forgetting” in Older People. Scholars Journal of Applied Medical Sciences. https://doi.org/10.36347/sjams.2020.v08i07.014
17. Ancoli‐Israel, S., & Cooke, J. R. (2005). Prevalence and Comorbidity of Insomnia and Effect on Functioning in Elderly Populations. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2005.53392.x
18. Anderson, D. K., & Sullivan, K. A. (2017). Cognitive assessment. Routledge eBooks. https://doi.org/10.4324/9781351258043-6
19. Anderson, S. W., Damásio, H., Tranel, D., & Damásio, A. R. (2000). Long-Term Sequelae of Prefrontal Cortex Damage Acquired in Early Childhood. Developmental Neuropsychology. https://doi.org/10.1207/s1532694202anderson
20. Anderson, S. W., Rizzo, M., Dawson, J. D., Myers, R., & Ball, K. (2000). Visual attention impairments in Alzheimer’s disease. Neurology. https://doi.org/10.1212/wnl.54.10.1954
21. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
22. Andreou, C., & Bozikas, V. P. (2012). The predictive significance of neurocognitive factors for functional outcome in bipolar disorder. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e32835a2acf
23. Andres, J., & Macheta, A. (1998). [Persistent vegetative state: medical, moral, legal and economic aspects].. PubMed.
24. Anticevic, A., Krystal, J. H., & Barch, D. M. (2013). Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches toward understanding cognitive deficits. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139003872.013
25. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
26. Apostolova, L. G. (2014). Dementia. https://doi.org/10.2217/ebo.13.306
27. Archer, K. J., & Pammer, K. (2021). Dyslexia. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0029348
28. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
29. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
30. Arlinger, S. (2003). Negative consequences of uncorrected hearing loss—a review. International Journal of Audiology. https://doi.org/10.3109/14992020309074639
31. Arnaldi, D., Morbelli, S., Morrone, E., Campus, C., & Nobili, F. (2012). Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging.. PubMed.
32. Arrowsmith, J. E. (2010). Central nervous system. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199209101.003.05
33. Arsanti, N. M., & Wreksoatmodjo, B. R. (2025). Tata Laksana Gangguan Kognitif di Layanan Primer. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v52i9.1653
34. Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and Management of Dementia: Review. JAMA. https://doi.org/10.1001/jama.2019.4782
35. Arvedson, J. C., & Simon, D. (1998). Acquired Neurologic Deficits in Young Children: A Diagnostic Journey with Dora. Seminars in Speech and Language. https://doi.org/10.1055/s-2008-1064037
36. Autor, J. L. M. C., & Principal, C. M. A. C. O. T. (2018). Demencia tipo Alzheimer vs pseudo demencia por depresión. Estudio neuropsicológico de un caso. XII CONGRESO DE POSGRADO EN PSICOLOGÍA | UNAM | 2018.
37. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
38. Autora, M. C. D. T., & Principal, C. I. Y. D. R. P. T. (2017). Funcionamiento cognitivo y alteraciones pragmáticas en pacientes con Esclerosis Múltiple.
39. Avendaño, M. L. P., Rincón, C. M., Tejada, J. V., & Etchepareborda, M. C. (2020). Variantes de neurodesarrollo en pacientes con diagnóstico de agenesia del cuerpo calloso completa y parcial. Revista Neuropsicologia Latinoamericana.
40. Azaraeen, S., & Memarian, S. (2015). Comparison of cognitive failures in addicts and non addicts. https://doi.org/10.1109/cogsci.2015.7426663
41. Bajaj, J. S. (2008). Management options for minimal hepatic encephalopathy. Expert Review of Gastroenterology & Hepatology. https://doi.org/10.1586/17474124.2.6.785
42. Bak, T. H., & Hodges, J. R. (1998). The neuropsychology of progressive supranuclear palsy. Neurocase. https://doi.org/10.1080/13554799808410610
43. Baker, D., Adamson, P., & Greenwood, J. (2003). Characterisation of cognitive impairment in schizophrenia.
44. Balažinec, M., Širić, L., Maljković, L., & Marijan, K. (2022). Acquired non-specific stuttering in Parkinson’s disease. Logopedija. https://doi.org/10.31299/log.12.1.4
45. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
46. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
47. Ballard, C., O’Brien, J. T., James, I. A., & Swann, A. (2001). Management of other behavioural and psychological symptoms in dementia. https://doi.org/10.1093/oso/9780192631756.003.0019
48. Ballard, C., Stephens, S., Kenny, R. A., Kalaria, R. N., Tovée, M. J., & O’Brien, J. T. (2003). Profile of Neuropsychological Deficits in Older Stroke Survivors without Dementia. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000069994
49. Banazak, D. A. (2000). Minor depression in primary care.. PubMed.
50. Baquero, M., Blasco, R., Campos-García, A., Garcés, M., Fages, E., & Andreu-Català, M. (2004). Estudio descriptivo de los trastornos conductuales en el deterioro cognitivo leve. Revista de Neurología. https://doi.org/10.33588/rn.3804.2003541
51. Barakat, B., Agosti, R., Ruggeri, E., Tonini, V., Cervellera, M., Guidetti, E., Cevenini, M., Imbrogno, A., Fabbri, D., Pareo, I., Fucili, A., Corinaldesi, R., Stanghellini, V., Pezzilli, R., & Giorgio, R. D. (2012). Atypical presentation of acute idiopathic megacolon in a 14-year-old patient. Emergency Care Journal. https://doi.org/10.4081/ecj.2012.3.5
52. Barch, D. M. (2003). Cognition in Schizophrenia. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.01251
53. Bargiotas, P., & Bassetti, C. L. (2017). Sleep-related movement disorders and disturbances of motor control. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000466
54. Barker, R. A., & Redfern, C. (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
55. Barnett, J. H., Salmond, C. H., Jones, P. B., & Sahakian, B. J. (2006). Cognitive reserve in neuropsychiatry. Psychological Medicine. https://doi.org/10.1017/s0033291706007501
56. Barquero, L. A., Wilson, L. M., Benedict, S. L., Lindström, E. R., Harris, H. C., & Cutting, L. E. (2012). Executive functions in learning disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511977954.012
57. Barrera, K., Yochim, B. P., & Yutsis, M. (2015). Neuropsychological Assessment. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa188
58. Barreto, D. M. R. (2018). Trastorno Neurocognitivo Mayor en un adulto joven. DOAJ (DOAJ: Directory of Open Access Journals).
59. Barrett, A. M. (2010). Rose-Colored Answers: Neuropsychological Deficits and Patient-Reported Outcomes after Stroke. Behavioural Neurology. https://doi.org/10.1155/2010/628257
60. Barrett, A. M. (2010). Rose-colored answers: neuropsychological deficits and patient-reported outcomes after stroke.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.3233/ben-2009-0250
61. Barré, M. (2013). Influence de la cognition sociale (Théorie de l'Esprit) sur la rémission fonctionnelle de la dépression et l'aptitude professionnelle.
62. Basagni, B., & Navarrete, E. (2025). Suggestions for the decision making in subjective cognitive complaints. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-024-02875-8
63. Basak, A. K., & Chatterjee, T. (2016). Structural and Neurochemical Alterations in Brain Regions of Depression and Suicide Patients. Clinical Depression. https://doi.org/10.4172/2572-0791.1000117
64. Bassetti, C. L. (2001). Disturbances of consciousness and sleep–wake functions. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511586521.015
65. Basura, G. J., Adams, M. E., Monfared, A., Schwartz, S., Antonelli, P. J., Burkard, R., Bush, M. L., Bykowski, J., Colandrea, M., Derebery, J., Kelly, E. A., Kerber, K. A., Koopman, C. F., Kuch, A. A., Marcolini, E. G., McKinnon, B. J., Ruckenstein, M. J., Valenzuela, C. V., Vosooney, A., ... Buchanan, E. M. (2020). Clinical Practice Guideline: Ménière’s Disease. Otolaryngology. https://doi.org/10.1177/0194599820909438
66. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
67. Baumard, J., Lesourd, M., Guezouli, L., & Osiurak, F. (2021). Physical understanding in neurodegenerative diseases. Cognitive Neuropsychology. https://doi.org/10.1080/02643294.2022.2071152
68. Baune, B. T. (2021). Cognitive dimensions of major depressive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198835554.003.0001
69. Baxter, J. D., & Young, L. (2022). Cognitive impairment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198766223.003.0043
70. Baxter, P. (2015). States of consciousness: new insights and further questions. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.12666
71. Beaudreau, S. A., & Gould, C. E. (2015). Definition of Mental Disorder. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa190
72. Bechtold, K. T., & Hosey, M. M. (2017). Consciousness. Taylor & Francis eBooks. https://doi.org/10.4324/9781315271743-15
73. Becker, S. P., & Barkley, R. A. (2018). Sluggish cognitive tempo. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198739258.003.0015
74. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
75. Beghi, M., Cornaggia, C., Frigeni, B., & Beghi, E. (2006). Learning Disorders in Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00681.x
76. Behrman, S., & Ebmeier, K. P. (2014). Can exercise prevent cognitive decline?. PubMed.
77. Belagaje, S., & Bonomo, J. (2012). A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000138
78. Bellivier, F. (2012). [Cognitions and functioning in euthymic bipolar patients: screening and treatment].. Encephale-revue De Psychiatrie Clinique Biologique Et Therapeutique.
79. Bender, C. M., & Merriman, J. D. (2014). Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?. PubMed.
80. Bermejo‐Pareja, F., & Puertas‐Martín, V. (2012). Cognitive features of essential tremor: a review of the clinical aspects and possible mechanistic underpinnings.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7916/d89w0d7w
81. Bernardin, F., Maheut-Bosser, A., & Paillé, F. (2014). [Cognitive impairment of alcohol-dependent subjects].. PubMed.
82. Bertrand, E., Azar, M., Rizvi, B., Brickman, A. M., Huey, E. D., Habeck, C., Landeira-Fernandez, J., Mograbi, D. C., & Cosentino, S. (2018). Cortical thickness and metacognition in cognitively diverse older adults.. Neuropsychology. https://doi.org/10.1037/neu0000458
83. Bhandurge, A. P., Kshirsagar, S., & Pratapwar, A. S. (2012). EVALUATION OF THE EFFECT OF VIGNA RADIATA LINN ON SCOPOLAMINE INDUCED WORKING AND MEMORY DEFICITS IN MICE BY USING DIFFERENT MODELS. International Journal of Research in Ayurveda and Pharmacy. https://doi.org/10.7897/2277-4343.03530
84. Bielefeldt, K., Tuteja, A. K., & Nusrat, S. (2016). Disorders of gastrointestinal hypomotility. F1000Research. https://doi.org/10.12688/f1000research.8658.1
85. Bigio, M. R. D. (2021). Neuronal Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.030
86. Bilyukov, R., Nikolov, M., Pencheva, V., Georgiev, O., Mondeshki, T., & Milanova, V. (2018). Cognitive Impairment and Affective Disorders in Patients With Obstructive Sleep Apnea Syndrome. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2018.00357
87. Birch, E. S., Stark, B. C., & Neumann, D. (2024). Factors related to social inferencing performance in moderate-severe, chronic TBI. Brain Injury. https://doi.org/10.1080/02699052.2024.2361634
88. Bird, M. I. (2000). Psychosocial Rehabilitation for Problems Arising from Cognitive Deficits in Dementia. https://doi.org/10.1093/oso/9780195119855.003.0013
89. Bitencourt, E. M., Kuerten, C. M. X., Budny, J., & Tuon, T. (2019). Doença de alzheimer: aspectos fisiopatológicos, qualidade de vida, estrategias terapêuticas da fisioterapia e biomedicina.. Inova Saúde. https://doi.org/10.18616/inova.v8i2.3573
90. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
91. Bivoleanu, A., Avasiloaiei, A., Moscalu, M., & Stamatin, M. (2017). The Role of Follow-up in Monitoring the Outcomes of Prematurity in a Cohort of Romanian Infants. Balkan Medical Journal. https://doi.org/10.4274/balkanmedj.2015.1125
92. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
93. Blanco, A. P., López, M. L., Machado, I. C., González, M. V., Costa, X. C., Pérez, V. B., Spuch, C., & Lamas, F. O. (2019). Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día. African journal of rhetoric. https://doi.org/10.21134/haaj.v19i1.412
94. Blanco, S., Mitra, S., Howard, C. J., & Sumich, A. (2022). Psychological trauma, mood and social isolation do not explain elevated dissociation in functional neurological disorder (FND). Personality and Individual Differences. https://doi.org/10.1016/j.paid.2022.111952
95. Blennow, G., Jaeken, J., & Wiklund, L. M. (1991). Neurological Findings in the Carbohydrate‐deficient Glycoprotein Syndrome. Acta Paediatrica. https://doi.org/10.1111/j.1651-2227.1991.tb12024.x
96. Boeve, B. F. (2004). Asymmetric cortical degeneration syndrome: semantic dementia. https://doi.org/10.1093/oso/9780195177442.003.0001
97. Boland, J. W., Lawlor, P. G., & Bush, S. H. (2019). Delirium: non-pharmacological and pharmacological management. BMJ Supportive & Palliative Care. https://doi.org/10.1136/bmjspcare-2019-001966
98. Bonnet, M. H., & Arand, D. L. (2008). Chronic insomnia. CRC Press eBooks. https://doi.org/10.3109/9780203091715-12
99. Bonnier, C., Marique, P., Hout, A. V., & Potelle, D. (2007). Neurodevelopmental Outcome After Severe Traumatic Brain Injury in Very Young Children: Role for Subcortical Lesions. Journal of Child Neurology. https://doi.org/10.1177/0883073807302604
100. Boon, P., Breuer, L. E. M., Grevers, E., Bernas, A., Bergmans, J., Besseling, R. M., Klooster, D., Louw, A. D., Mestrom, R., Vonck, K., Zinger, S., & Aldenkamp, A. P. (2016). Cognitive deterioration in adult epilepsy: clinical characteristics of “Accelerated Cognitive Ageing”. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12700
101. Boone, K. B. (2008). Fixed Belief in Cognitive Dysfunction Despite Normal Neuropsychological Scores: Neurocognitive Hypochondriasis?. The Clinical Neuropsychologist. https://doi.org/10.1080/13854040802441135
102. Borlongan, C., Kaelber, S., & Pantcheva, P. (2016). Drug- and cell-based therapies for targeting neuroinflammation in traumatic brain injury. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.193231
103. Bortolato, B., Carvalho, A. F., & McIntyre, R. S. (2015). Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527313666141130203823
104. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2017). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.5281/zenodo.4681378
105. Bosanac, B., Dominik, P., Gabrić, P., Hrstić, A., Ključarić, D. K., Kužina, I., Sović, M. S., & Vandek, M. (2020). Lexical-semantic categorisation in patients of schizophrenia. https://doi.org/10.17605/osf.io/5z9c4
106. Bosch, W. V. D., & Weel‐Baumgarten, E. V. (2003). [Depression: longer-lasting episode not an automatic indication for referral].. PubMed.
107. Bouffet, É., McGee, P., & Beal, D. S. (2004). Pediatric Neurology. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198508434.003.0011
108. Bourdeanu, L., Hein, M. J., & Liu, E. A. (2015). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0011
109. Bowie, C. R., & Harvey, P. D. (2006). Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/nedt.2006.2.4.531
110. Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., & Foster, N. L. (2001). Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss. Archives of Neurology. https://doi.org/10.1001/archneur.58.3.411
111. Braitman, A. L. (2014). Le concept de réactivité cognitive comme marqueur de vulnérabilité psychique du sujet âgé. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.271
112. Brandish, E. K., & Baldwin, D. S. (2012). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2012.08.017
113. Brandt, J., & Butters, N. (1996). Neuropsychological Characteristics of Huntington’s Disease. https://doi.org/10.1093/oso/9780195090734.003.0014
114. Brankovi, S. (2012). Assessment of Brain Monoaminergic Signaling Through Mathematical Modeling of Skin Conductance Response. InTech eBooks. https://doi.org/10.5772/34164
115. Bremer, E., Saini, P., Broyles, S., Rye, D. B., & Trotti, L. M. (2018). 0617 Working Memory and Psychomotor Vigilance Performance After Brief Naps in Hypersomnolent Patients: MSLT Correlates. SLEEP. https://doi.org/10.1093/sleep/zsy061.616
116. Brennan, C. (2021). Learning Disabilities. https://doi.org/10.1002/9781119606987.ch11
117. Brody, D. L. (2014). Dizziness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0014
118. Brody, D. L. (2014). Executive Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0018
119. Brody, D. L. (2014). Memory Impairment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0017
120. Bronstein, A. M., & Lempert, T. (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
121. Brown, J., Huntley, D., Erik, W., Wiley, C. R., Cich, J., & Morgan, S. (2017). Confabulation: Implications for Criminal Justice, Forensic Mental Health, and Legal Professionals. Journal of Neurology and Neuroscience. https://doi.org/10.21767/2171-6625.1000217
122. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
123. Bruna, O., Signo, S., & Subirana-Mirete, J. (2011). Llenguatge i envelliment: una visió des de la neuropsicologia. Aloma: revista de psicologia, ciències de l'educació i de l'esport Blanquerna.
124. Brüne, M. (2008). Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199207688.003.0009
125. Brüne, M. (2008). Psychiatric Assessment. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199207688.003.0006
126. Buckley, P., & Foster, A. (2014). Schizophrenia. https://doi.org/10.1007/978-3-7091-0715-7_4
127. Buckley, T. M., & Guilleminault, C. (2008). Index. CRC Press eBooks. https://doi.org/10.3109/9781420019926-54
128. Budson, A. E. (2014). Memory Systems in Dementia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199928453.003.0004
129. Budson, A. E., & Kensinger, E. A. (2023). What else can go wrong with your memory?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780197607732.003.0014
130. Buitelaar, J. K. (2003). Why Have Drug Treatments Been So Disappointing?. Novartis Foundation symposium. https://doi.org/10.1002/0470869380.ch14
131. Burgess, J., Costa, T., & Cousins, D. A. (2020). Clinical assessment and investigation in psychiatry. Medicine. https://doi.org/10.1016/j.mpmed.2020.08.009
132. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
133. Burns, A. (2000). Behavioral and Psychological Symptoms of Dementia and Caregiver Burden. International Psychogeriatrics. https://doi.org/10.1017/s1041610200007262
134. Burns, L. (2008). Possible herbal medicinedrug interactions in the perioperative period : clinical pharmacology. CME: Your SA Journal of CPD.
135. Butters, M. A., López, O. L., & Becker, J. T. (1996). Focal temporal lobe dysfunction in probable Alzheimer's disease predicts a slow rate of cognitive decline. Neurology. https://doi.org/10.1212/wnl.46.3.687
136. Bäckman, L., & Small, B. J. (1998). A continuity view of episodic memory impairment: Illustrations from Alzheimer´s disease and major depression.
137. Búa, B. A. (2004). Estudio de las dificultades lectoras en niños mediante potenciales cerebrales relacionados con eventos (PEs).
138. Büla, C. (2019). Dementia and Neurocognitive Disability. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190459802.003.0003
139. Cabé, N., Lanièpce, A., Boudehent, C., Vabret, F., & Pitel, A. (2019). [Alcohol induced neurocognitive disorder: screening strategies and tools].. HAL (Le Centre pour la Communication Scientifique Directe).
140. Caetano, F., Araújo, M., Samouco, A., & Carvalho, S. (2021). 518 - AUTOIMMUNE DEMENTIA – WHEN TO SUSPECT?. International Psychogeriatrics. https://doi.org/10.1017/s1041610221002131
141. Calabrò, R. S., Milardi, D., Cacciola, A., Marra, A., Digangi, G., Casella, C., Manuli, A., Luca, R. D., Silvestri, R., & Bramanti, P. (2016). Moving into the wide clinical spectrum of consciousness disorders: Pearls, perils and pitfalls. Medicina. https://doi.org/10.1016/j.medici.2016.01.002
142. Campos, M. P. D. O., Hassan, B. J., Riechelmann, R. P., & Giglio, A. D. (2011). Cancer-related fatigue: a review. Revista da Associação Médica Brasileira (English Edition). https://doi.org/10.1016/s2255-4823(11)70046-7
143. Campos-Castelló, J. (2000). [Epilepsies and language disorders].. PubMed.
144. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
145. Cardoner, N., Cebrià, A., López‐Solà, C., Serra-Blasco, M., Massons, C., Muriel, V., Navarra‐Ventura, G., Via, E., Cobo, J., & Golberg, X. (2017). Neuropersonaltrainer-mh: A New Computerized Platform for the Cognitive Remediation in Schizophrenia and Bipolar Disorders. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.125
146. Carota, A., Diéguez, S., & Bogousslavsky, J. (2005). Psychopathology of stroke. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
147. Carr, D. B. (2008). Current Knowledge on Medical Fitness-to-Drive: The Role of the Clinician.
148. Carvalho, A. F., Miskowiak, K. W., Hyphantis, T., Köhler, C. A., Alves, G. S., Bortolato, B., Sales, P. G. O., Machado‐Vieira, R., Berk, M., & McIntyre, R. S. (2015). Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527313666141130203627
149. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
150. Caselli, R. J. (2000). Parkinsonism in Primary Degenerative Dementia. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-410-8_20
151. Caselli, R. J. (2015). Focal Cognitive Syndromesa. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214883.003.0023
152. Castro, P. D. (2008). Paciente con alteración de conciencia en urgencias Patients with alteration of consciousness in the emergency department.
153. Castro, P. D. (2008). Paciente con alteración de conciencia en urgencias. Anales del Sistema Sanitario de Navarra. https://doi.org/10.4321/s1137-66272008000200008
154. Cerdas, M. T. G. (2018). Narcolepsia: abordaje diagnostico y terapeutico. Revista Medica Sinergia. https://doi.org/10.31434/rms.v3i12.161
155. Chandran, S. A. (2013). A Study of Cognitive Functioning in Aging.
156. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
157. Chapman, K. A. (2016). Systemic organic acidemias: Identification, diagnosis, management and long term complications. Journal of Pediatric Biochemistry. https://doi.org/10.3233/jpb-140126
158. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
159. Chatterjee, D., Gavas, R., Chakravarty, K., Sinha, A., & Lahiri, U. (2018). Eye movements - an early marker of cognitive dysfunctions. https://doi.org/10.1109/embc.2018.8513307
160. Chatterjee, S., Rudra, A., Kirtania, J., Sengupta, S., Moitra, G., Sirohia, S., Wankhade, R., & Banerjee, S. (2006). Postoperative delirium. Indian Journal of Critical Care Medicine. https://doi.org/10.4103/0972-5229.29842
161. Chaudhuri, K., Samarakoon, S., Chandola, H., Kumar, R., & Ravishankar, B. (2011). Evaluation of diet and life style in etiopathogenesis of senile dementia: A survey study. AYU (An International Quarterly Journal of Research in Ayurveda). https://doi.org/10.4103/0974-8520.92554
162. Chauhan, P., Mishra, M., Koul, B., Sharma, M. M., & Yadav, D. (2021). Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527320666210319111852
163. Chen, S. T., Sultzer, D. L., Hinkin, C. H., Mahler, M. E., & Cummings, J. L. (1998). Executive Dysfunction in Alzheimer's Disease. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.10.4.426
164. Chen, Y., Garcia, G. E., Huang, W., & Constantini, S. (2014). The Involvement of Secondary Neuronal Damage in the Development of Neuropsychiatric Disorders Following Brain Insults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00022
165. Cheng, C., Hsieh, Y., Chang, C., Hsiao, F., Chen, L., & Wang, P. (2024). Effects of 6-Month Combined Physical Exercise and Cognitive Training on Neuropsychological and Neurophysiological Function in Older Adults with Subjective Cognitive Decline: A Randomized Controlled Trial. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-231257
166. Chevallier, E., Melac, A. T., Krebs, M., Mitelman, S. A., Buchsbaum, M. S., & Bralet, M. (2018). F125. POOR OUTCOME SCHIZOPHRENIA (KRAEPELINIAN SUB-TYPE): SOCIAL COGNITIVE AND NEURODEVELOPMENTAL MARKERS. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sby017.656
167. Chiba, S., & Tamura, Y. (2015). [Clinical features of sleep disorders in older adults].. PubMed.
168. Choi, M. S., & Kim, S.-Y. (2010). P3-110: Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2010.05.1607
169. Chopra, K., & Tiwari, V. (2012). Tocotrienol and Cognitive Dysfunction Induced by Alcohol. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-047-2_14
170. Chou, K. L., & Cronin‐Golomb, A. (2013). Feeling the need … the need for speed (of processing training) in Parkinson disease. Neurology. https://doi.org/10.1212/wnl.0b013e3182a82581
171. Chou, S.-T., Pogach, M., & Rock, L. K. (2022). Promoting sleep and other simple, non-pharmacological interventions for preventing and treating ICU Delirium: case report. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-1374870/v1
172. Choudhary, A. K., Loganathan, S., & Kuppusamy, M. (2021). A Sedentary Lifestyle and Cognitive Function. Book Publisher International (a part of SCIENCEDOMAIN International). https://doi.org/10.9734/bpi/cdhr/v6/7457d
173. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
174. Chow, W., Khullar, A., Lalla, F., Lessard, S., Lowe, A., & McIntosh, D. (2025). Practical Recommendations for Hypnotic Switching in Insomnia Management: A Canadian Expert Clinical Framework. Canadian Primary Care Today. https://doi.org/10.58931/cpct.2025.3s0148
175. Chrestian, N. (2020). Hereditary Neuropathy with Liability to Pressure Palsies.
176. Cipriani, G., Danti, S., Picchi, L., Nuti, A., & Fiorino, M. D. (2020). Daily functioning and dementia. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642020dn14-020001
177. Cipriani, G., Danti, S., Picchi, L., Nuti, A., & Fiorino, M. D. (2020). Daily functioning and dementia/ Atividades da vida diária e demência.
178. Ciszowski, K., & Mietka-Ciszowska, A. (2013). [Consciousness disturbances during poisonings: pathophysiology, clinical picture, and basic principles of diagnosis and management].. PubMed.
179. Clanchy, K. (2013). Promoting Physical Activity in People with Brain Impairments.
180. Clarke, C. (2022). Cognition, Cortical Function and Dementias. Neurology. https://doi.org/10.1002/9781119235699.ch5
181. Clay, S., Allen, J. V., & Parran, T. (2008). A Review of Addiction. Postgraduate Medicine. https://doi.org/10.3810/pgm.2008.07.1802
182. Cleeland, C. S., & Mendoza, T. R. (2010). Symptom measurement by patient report. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511780868.028
183. Collier, L., & Truman, J. (2008). Exploring the multi-sensory environment as a leisure resource for people with complex neurological disabilities. Neurorehabilitation. https://doi.org/10.3233/nre-2008-23410
184. Colón‐Emeric, C., Whitson, H. E., Pavon, J. M., & Hoenig, H. (2013). Functional decline in older adults.. PubMed.
185. Combs, S., Kluger, B. M., & Kutner, J. S. (2013). Research Priorities in Geriatric Palliative Care: Nonpain Symptoms. Journal of Palliative Medicine. https://doi.org/10.1089/jpm.2013.9484
186. Conde, I. L., Fernández‐Montalvo, J., Ustárroz, J. T., González, N. L., & López‐Goñi, J. J. (2010). Rendimiento neuropsicológico en la adicción a la cocaína: una revisión crítica. Revista de Neurología. https://doi.org/10.33588/rn.5107.2010395
187. Conde-Guzón, P. A., Conde-Guzón, M. J., Bartolomé-Albistegui, M. T., & Quirós-Expósito, P. (2009). [Neuropsychological profiles associated with the children's oral language disorders].. PubMed.
188. Constantinescu, C. S., & Lim, S. (2018). Weakness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0044
189. Cooper, L., Copeland, S., Dailey, S., Downey, D., Petersen, M. C., Stimson, C., & Dyke, D. C. V. (2008). Feeding and swallowing dysfunction in genetic syndromes. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.19
190. Cooper, S. (2005). The clinical assessment of the patient with early dementia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.081133
191. Cooper, S., & Prasher, V. P. (1998). Maladaptive behaviours and symptoms of dementia in adults with Down's syndrome compared with adults with intellectual disability of other aetiologies. Journal of Intellectual Disability Research. https://doi.org/10.1046/j.1365-2788.1998.00135.x
192. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
193. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
194. Corrêa, C. R. G. L. (2013). Attention – Deficit Hyperactivity Disorder (ADHD) in Psychiatry and Psychoanalysis. InTech eBooks. https://doi.org/10.5772/52880
195. Corsonello, A., Pedone, C., & Incalzi, R. A. (2007). Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD. Current Respiratory Medicine Reviews. https://doi.org/10.2174/157339807780599162
196. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
197. Cortés, V. A. L. (2018). Características neuropsicológicas de pacientes con enfermedad de Parkinson sin demencia. https://doi.org/10.14201/gredos.139596
198. Costa, D. C. (1998). Dementia. Clinical Nuclear Medicine. https://doi.org/10.1007/978-1-4899-3356-0_23
199. Cousins, D. A., McAllister‐Williams, R. H., & Lunn, B. (2016). Clinical assessment and investigation in psychiatry. Medicine. https://doi.org/10.1016/j.mpmed.2016.08.004
200. Cox, D. M., & Butler, M. G. (2015). The 15q11.2 BP1–BP2 Microdeletion Syndrome: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms16024068
201. Cristina, L., Făget, D., Chiriță, V., Chiriță, R., & Manea, M. (2019). "Alternative therapies and management of dementia in Alzheimer's disease". Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.04.07
202. Cristofor, A.-C., Popa, T., Crețeanu, A., Rusu, G., & Mititelu-Tarțău, L. (2016). Farmacoterapia depresiei la pacientul vârstnic. Farmacist ro.
203. Cummings, J. (1988). Psychological Dysfunction Accompanying Subcortical Dementias. Annual Review of Medicine. https://doi.org/10.1146/annurev.med.39.1.53
204. Cummings, J. L. (1988). Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198878800100106
205. Cummings, J. L., & Benson, D. F. (1988). Psychological Dysfunction Accompanying Subcortical Dementias. Annual Review of Medicine. https://doi.org/10.1146/annurev.me.39.020188.000413
206. Cummings, J. L., & Zhong, K. (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
207. Cupelli, R. H., Weise, A., Barbero, M., & Kool, J. (2017). Interim report: Development and evaluation of a three-week inpatient fatigue management education protocol for persons with MS-related fatigue.
208. Custodio, N., Castro, S., Herrera‐Pérez, E., Lira, D., Prado, L. N. D., Cortijo, P., & Montesinos, R. (2013). Afasias progresivas primarias: las afasias de lenta evolución a demencia.. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v75i3.1227
209. Custodio, N., Montesinos, R., & López‐Góngora, M. (2018). Deterioro cognitivo en pacientes con esclerosis múltiple. Anales de la Facultad de Medicina. https://doi.org/10.15381/anales.v79i4.15641
210. D.Vaidya, H., Wairagade, S., Rathod, D. P., Ambad, R., & Kalambe, M. (2021). Dyslexia Management through Ayurveda: A Conceptual Study. NVEO - NATURAL VOLATILES & ESSENTIAL OILS Journal | NVEO.
211. Dan, B. (2023). Neurodevelopmental impairment advantage: The ability capital. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15723
212. Dana, A. I. (2021). Mild Cognitive Impairment is an Early Stage of Memory Loss. Journal of Aging and Geriatric Medicine.
213. Daniel, M., Mathew, G., & Neppolian, B. (2021). METAL DOPED NiCo LDH@REDUCED GRAPHENE OXIDE FOR IMPROVED ELECTROANALYTICAL PERFORMANCE TOWARDS SELECTIVE DETECTION OF DOPAMINE. SPAST Abstracts.
214. Dara, N., Sayyari, A., & Imanzadeh, F. (2014). Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosis.. PubMed.
215. Dardiotis, E., Giamouzis, G., Mastrogiannis, D., Vogiatzi, C., Skoularigis, J., Triposkiadis, F., & Hadjigeorgiou, G. M. (2012). Cognitive Impairment in Heart Failure. Cardiology Research and Practice. https://doi.org/10.1155/2012/595821
216. Das, C., & Joseph, S. (2005). Falls in elderly.. PubMed.
217. Daude, H., Bousquet-Jacq, N., Kanel, K. V., Boulay, N., Faye, M., Coquery, M., Tronel, S., & Beltran, M. (2015). Repérage et prise en charge multidisciplinaire des troubles du développement cognitif et relationnel de l’enfant né prématurément. Contraste. https://doi.org/10.3917/cont.041.0151
218. Daum, I., & Ackermann, H. (1997). Nondeklaratives Gedächtnis - neuropsychologische Befunde und neuroanatomische Grundlagen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-996316
219. David, A. S. (2010). 031 Self awareness and insight in neuropsychiatric disorders. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.217554.31
220. David, R. (2025). Are New Technologies suitable for Real-World Management of Dementia?. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.161
221. Davis, J., & Tremont, G. (2007). Neuropsychiatric aspects of hypothyroidism and treatment reversibility. .. PubMed.
222. Deary, I. J., Sommerfield, A., McAulay, V., & Frier, B. M. (2003). Moderate hypoglycaemia obliterates working memory in humans with and without insulin treated diabetes. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.74.2.278-a
223. Dedic, N., Sandra, M., & Jan (2011). Mouse Models of Depression. InTech eBooks. https://doi.org/10.5772/27498
224. Degenhardt, L., Hall, W., & Lynskey, M. T. (2003). What is comorbidity and why does it occur?. PsycEXTRA Dataset. https://doi.org/10.1037/e677042010-003
225. DeJong, R. N. (1969). Memory Loss due to Hippocampal Lesions. Archives of Neurology. https://doi.org/10.1001/archneur.1969.00480100015001
226. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
227. Delgado, C., Vergara, R. C., Martínez, M., Musa, G., Henríquez, F., & Slachevsky, A. (2017). [P2–266]: APATHY IMPAIRS ADVANCED ACTIVITIES OF DAILY LIVING IN VERY MILD ALZHEIMER DISEASE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2017.06.919
228. Delgado, S., Wassenaar, E., & Strawn, J. R. (2011). Does Your Patient Have a Psychiatric Illness or Nonverbal Learning Disorder? Clinical Clues Help Differentiate Overlapping Symptoms and Syndromes. Current psychiatry.
229. Denckla, M. B. (1996). Biological Correlates of Learning and Attention. Journal of Developmental & Behavioral Pediatrics. https://doi.org/10.1097/00004703-199604000-00011
230. Deonna, T. (2004). Cognitive and behavioral manifestations of epilepsy in children. CRC Press eBooks. https://doi.org/10.1201/b13560-42
231. Deonna, T. (2010). [Cognitive and behavioral consequences of epilepsy during the course of brain development].. PubMed.
232. Derchi, C., Ceruti, S., & Giubbilo, I. (2021). Clinical Ethics and Disorder of Consciousness. Studia Universitatis Babeş-Bolyai Bioethica. https://doi.org/10.24193/subbbioethica.2021.spiss.20
233. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
234. Derouesné, C. (2006). Dementia with Lewy bodies: third report of DLB consortium. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
235. Derouesné, C. (2006). Démence à corps de Lewy : nouveau consensus. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
236. Desai, S. V., Law, T. J., & Needham, D. M. (2010). Long-term complications of critical care. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e3181fd66e5
237. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
238. Desmond, D. W., Erkinjuntti, T., Sano, M., Cummings, J. L., Bowler, J. V., Pasquier, F., Moroney, J. T., Ferris, S. H., Stern, Y., Sachdev, P. S., & Hachinski, V. (1999). The cognitive syndrome of vascular dementia: implications for clinical trials.. PubMed.
239. Desmond, D. W., Erkinjuntti, T., Sano, M., Cummings, J. L., Bowler, J. V., Pasquier, F., Moroney, J. T., Ferris, S. H., Stern, Y., Sachdev, P. S., & Hachinski, V. C. (1999). The Cognitive Syndrome of Vascular Dementia: Implications for Clinical Trials. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199912003-00005
240. Desseilles, M., Sterpenich, V., Dang‐Vu, T. T., & Schwartz, S. (2011). REM sleep and emotion regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511921179.044
241. Devinsky, O., & D’Esposito, M. (2003). Attention and Attentional Disorders. https://doi.org/10.1093/oso/9780195137644.003.0004
242. Devoto, A., & Violani, C. (2015). Problematicità dei disturbi soggettivi: il caso dell' insonnia. RICERCHE DI PSICOLOGIA. https://doi.org/10.3280/rip2015-003008
243. Dewi, K. Y. F. (2022). MENGELOLA SISWA DENGAN KESULITAN BELAJAR MENULIS (DISGRAFIA). Daiwi Widya. https://doi.org/10.37637/dw.v8i5.909
244. Dhingra, L., Ahmed, E., Shin, J. G., Scharaga, E., & Magun, M. (2015). Cognitive Effects and Sedation. Pain Medicine. https://doi.org/10.1111/pme.12912
245. Dickenson, D., & Fulford, B. (2001). Basic concepts: your myth or mine?. https://doi.org/10.1093/oso/9780192628589.003.0003
246. Dickerson, B. C., & Sperling, R. A. (2007). Dementia: mild cognitive impairment and Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0005
247. Ding, K., Gupta, P. K., & Diaz‐Arrastia, R. (2016). Epilepsy after Traumatic Brain Injury. CRC Press, Taylor and Francis Group eBooks.
248. Doghramji, K. (2003). Treatment strategies for sleep disturbance in patients with depression.. PubMed.
249. Domoto‐Reilly, K., Sapolsky, D., & Dickerson, B. C. (2014). Mild Cognitive Impairment (MCI) Stage of the Frontotemporal Dementias: Early Diagnosis and Management. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.57
250. Donoso, S. A., González, V. R., González, R. P., & Pugin, A. A. (2008). Demencia semántica. Presentación de dos casos y revisión de la literatura Semantic dementia: Report of two casesd*.
251. Doskas, T., Vavougios, G. D., Karampetsou, P., Kormas, C., Synadinakis, E., Stavrogianni, K., Sionidou, P., Serdari, A., Vorvolakos, T., Iliopoulos, I., & Vadikolias, Κ. (2021). Neurocognitive impairment and social cognition in multiple sclerosis. International Journal of Neuroscience. https://doi.org/10.1080/00207454.2021.1879066
252. Douma, T. N., Millan, M. J., Olivier, B., & Groenink, L. (2011). Linking Stress and Schizophrenia: A Focus on Prepulse Inhibition. InTech eBooks. https://doi.org/10.5772/26944
253. Dragut, A. M., Danalache, I., Goanta, M., & Trifu, S. (2015). The Pathology of Cognitive and Language Disorganization–Between Hysteric Dissociation and Schizophrenic Split. Procedia - Social and Behavioral Sciences. https://doi.org/10.1016/j.sbspro.2015.03.081
254. Drake, K., & Casher, M. I. (2020). The Inpatient with Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/9781108656672.007
255. Drake, M. (2013). Trastornos cognitivos en la esquizofrenia.
256. Drane, D. L., & Locke, D. E. (2017). Mechanisms of Possible Neurocognitive Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190265045.003.0005
257. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
258. Drobizhev, М. Y., Galstyan, G. R., Surkova, E. V., Mel'nikova, O. G., & Divisenko, S. I. (2007). [Pain in diabetic neuropathy: psychosomatic aspects].. PubMed. https://doi.org/10.14341/probl200753643-47
259. Dubois, B., Pillon, B., & Agid, Y. (1996). Testing cognition may contribute to the diagnosis of movement disorders. Neurology. https://doi.org/10.1212/wnl.46.2.329
260. Duchowny, M., & Bourgeois, B. (2003). COEXISTING DISORDERS IN CHILDREN WITH EPILEPSY.
261. Duclos, C., Beauregard, M., Bottari, C., Ouellet, M., & Gosselin, N. (2014). The impact of poor sleep on cognition and activities of daily living after traumatic brain injury: A review. Australian Occupational Therapy Journal. https://doi.org/10.1111/1440-1630.12164
262. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
263. Duff, K., Mold, J. W., Roberts, M., & McKay, S. (2007). Medical burden and cognition in older patients in primary care: Selective deficits in attention. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.03.007
264. Dujardin, K., & Lopes, R. (2014). Apathy and impaired recognition of emotion: are they related in Parkinson’s disease?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-307224
265. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
266. Dunphy, L., Akin-Komolafe, T., & etheridge, Z. (2021). Mixed dementia and hyperactive delirium: a diagnostic challenge. BMJ Case Reports. https://doi.org/10.1136/bcr-2020-238542
267. Duntley, S. P. (2004). Insomnia in Primary Sleep Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_12
268. Dushanova, J. (2017). Senescence, prodromal dementia, electrophysiological biomarkers..
269. Dziegielewski, S. F. (2014). Quick References. https://doi.org/10.1002/9781394260577.bapp01
270. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
271. Ebadi, M., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2011). Non-motor Symptoms in Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2011.07.02.113
272. Ebadi, M., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2012). Non-motor Symptoms in Parkinson’s Disease. European Neurological Review. https://doi.org/10.17925/enr.2012.07.01.35
273. Elgallab, J., Charvet, L., & Krupp, L. (2018). A Case of Cognitive and Behavioral Decline leading to Onset of Pediatric Onset Multiple Sclerosis (P2.316). Neurology. https://doi.org/10.1212/wnl.90.15_supplement.p2.316
274. Elhadd, K., Bharambe, V., & Aj, L. (2018). Functional Cognitive Disorders: Can Sleep Disturbance Contribute to a Positive Diagnosis?. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000291
275. Elvevåg, B., & Goldberg, T. E. (2000). Cognitive Impairment in Schizophrenia Is the Core of the Disorder. Critical Reviews in Neurobiology. https://doi.org/10.1615/critrevneurobiol.v14.i1.10
276. Emilien, G., Durlach, C., Minaker, K. L., Winblad, B., Gauthier, S., & Maloteaux, J. (2004). Behavioral and psychological impairments. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7842-5_9
277. Erber, N. P., & Scherer, S. (1999). Sensory Loss and Communication Difficulties in the Elderly. Australasian Journal on Ageing. https://doi.org/10.1111/j.1741-6612.1999.tb00079.x
278. Erkinjuntti, T., Gauthier, S., Rockwood, K., inas, I. G., Sykes, L., Teunisse, S., Orgogozo, J. M., Erzigkeit, H., Gleeson, M., Kittner, B., Pontecorvo, M., Feldman, H., & Whitehouse, P. (1999). Outcome Measures for the Study of Activities of Daily Living in Vascular Dementia. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/00002093-199912003-00021
279. Errante, P. R. (2022). Canine Cognitive Dysfunction Syndrome a Challenge in Treatment and Improvement in Quality Life of Older Dogs. International Journal of Zoology and Animal Biology. https://doi.org/10.23880/izab-16000424
280. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
281. Esteves-Sousa, D., Albuquerque, M., Facucho-Oliveira, J., Santos, P. E. D., Costa, M. S., Chai, M. V., Mendonça, L., & Tropa, J. (2019). ANTIPSYCHOTIC AGENTS, UNDERNEATH THEIR ACTION – STRENGTHS AND SHORTCOMINGS. https://doi.org/10.26226/morressier.5d1a037657558b317a14069b
282. Ettinger, U., Möhr, C., Gooding, D. C., Cohen, A. S., Rapp, A. M., Haenschel, C., & Park, S. (2015). Cognition and Brain Function in Schizotypy: A Selective Review. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbu190
283. Evans, J. J. (2009). The Cognitive Group, Part 2: Memory. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581083.009
284. Evenden, J. L. (1999). Impulsivity: a discussion of clinical and experimental findings. Journal of Psychopharmacology. https://doi.org/10.1177/026988119901300211
285. Evered, L., Atkins, K. J., Silbert, B., & Scott, D. A. (2022). Acute peri‐operative neurocognitive disorders: a narrative review. Anaesthesia. https://doi.org/10.1111/anae.15613
286. Farah, M. J., & Feinberg, T. E. (2005). Patient-Based Approaches to Cognitive Neuroscience. https://doi.org/10.7551/mitpress/5268.001.0001
287. Farias, S. T., Mungas, D., & Reed, B. (2011). P4‐466: The relationship between informant and performance‐based measures of everyday function. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2011.09.159
288. Farinde, A. (2012). EXPLORING ALZHEIMER’S DISEASE (ALZHEIMER’S TYPE DEMENTIA). Deleted Journal.
289. Farinde, A. (2013). Laboratory Monitoring of Psychotropic Medications: Physician and Pharmacist Collaboration. Deleted Journal.
290. Farmer, M., Échenne, B., Drouin, R., & Bentourkia, M. (2017). Insights in Developmental Coordination Disorder. Current Pediatric Reviews. https://doi.org/10.2174/1573396313666170726113550
291. Faulkner, G., Gorczynski, P., & Arbour‐Nicitopoulos, K. P. (2015). Exercise as an Adjunct Treatment for Schizophrenia. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch38
292. Faustino, B. (2021). Neurocognition applied to psychotherapy: A brief theoretical proposal based on the complex neural network perspective. Applied Neuropsychology Adult. https://doi.org/10.1080/23279095.2021.1883615
293. Feng, J., Wu, Q., Zhang, D., & Chen, B.-Y. (2012). Hippocampal impairments are associated with intermittent hypoxia of obstructive sleep apnea.. PubMed.
294. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
295. Fernandes, C. F., Gonçalves, C. F., & Sousa, P. (2024). Learning Disabilities and Epilepsy: About a Clinical Case. Gazeta Médica. https://doi.org/10.29315/gm.v1i1.707
296. Fernando, A., & Robbins, T. W. (2011). Animal Models of Neuropsychiatric Disorders. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev-clinpsy-032210-104454
297. Fernández, A., Andreina, M. M., Hornero, R., Ortiz, T., & López-Ibor, J. J. (2010). [Analysis of brain complexity and mental disorders].. PubMed.
298. Fernández-Egea, E., & Jones, P. B. (2023). Schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.065
299. Fernández‐Jaén, A., Fernández‐Mayoralas, D. M., Fernández‐Perrone, A. L., Jiménez, A. L., Albert, J., López‐Martín, S., Calleja‐Pérez, B., Tirado, P., & López-Arribas, S. (2018). [Neurodevelopment and phenocopies of attention deficit hyperactivity disorder: differential diagnosis].. PubMed.
300. Fernández‐Jaén, A., Martín, S. L., Albert, J., Mayoralas, D. M. F., Perrone, A. L. F., Pérez, B., & Arribas, S. L. (2017). Trastorno por déficit de atención/hiperactividad. Revista de Neurología.
301. Ferro, J. M., & Madureira, S. (2002). Recovery from Cognitive and Behavioral Deficits. CRC Press eBooks. https://doi.org/10.1201/9780203908884-10
302. Fields, J. A., Norman, S., Straits-Tröster, K., & Tröster, A. I. (1998). The impact of depression on memory in neurodegenerative disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544378.020
303. Filippi, M., & Rocca, M. A. (2013). Let's rehabilitate cognitive rehabilitation in multiple sclerosis. Neurology. https://doi.org/10.1212/01.wnl.0000437311.96160.b3
304. Flachenecker, P. (2015). Fatigue bei Multipler Sklerose. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627622
305. Foerster, K., Joergens, S., & Baune, B. T. (2019). Clinical Characteristics of Social Cognitive Processes in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0015
306. Fond, G. (2015). Microbiote intestinal : un rôle potentiel dans les troubles psychiatriques majeurs. Une revue qualitative systématique. Première partie : aspects cliniques. Médecine. https://doi.org/10.1684/med.2015.1277
307. Fontenele, J. L., Moura, C. G. F., & Oliveira, G. D. P. (2021). Clinical and radiological features of main dementias. Revista Brasileira de Neurologia.
308. Fowler, N. R., Gao, S., Frame, A., Perkins, A. J., Monahan, P. O., & Boustani, M. (2011). P2‐432: Who refuses diagnostic assessment for dementia?. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2011.05.1305
309. Fox, C., Jimoh, F. O., & Cross, J. (2018). Intervention to prevent, delay or reduce frailty in community-living older adults..
310. Fragoso, Y. D., Rocha, F. B., Beloni, T. M. N., Orquiza, B., Rosa, P. B., Donadel, R. W., Aniceto, J. T., & Diniz, R. P. (2016). Driving Ability among Patients with Multiple Sclerosis: Can Legislation Be Provided on the Matter?. Critical Reviews in Physical and Rehabilitation Medicine. https://doi.org/10.1615/critrevphysrehabilmed.2017020023
311. Francis, J. (1997). Delirium. Geriatric medicine. https://doi.org/10.1007/978-1-4757-2705-0_60
312. Franklin, G. M. (1989). Cognitive Loss in Multiple Sclerosis. Archives of Neurology. https://doi.org/10.1001/archneur.1989.00520380066014
313. Franz, C., Ascherman, L., & Shaftel, J. (2017). Nonverbal Learning Disabilities. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195383997.003.0007
314. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
315. Frean, J., Jong, G. D., & Albrecht, R. (2008). Imaginary bugs, real distress: delusional parasitosis.. PubMed.
316. Freedman, R., Adler, L. E., Gerhardt, G. A., Waldo, M., Baker, N. J., Rose, G., Drebing, C., Nagamoto, H. T., Bickford, P. C., & Franks, R. D. (1987). Neurobiological Studies of Sensory Gating in Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/13.4.669
317. Freeman, D., & Waite, F. (2025). Sleep and circadian difficulties in schizophrenia: presentations, understanding, and treatment. Psychological Medicine. https://doi.org/10.1017/s0033291725000297
318. Fukuda, J. S., Pires, M. M., Fukuda, T. G., & Oliveira‐Filho, J. (2016). Atualização sobre diagnóstico e tratamento das demências rapidamente progressivas com base na experiência do Serviço. Revista Científica Hospital Santa Izabel. https://doi.org/10.35753/rchsi.v3i2.475
319. Funder, K. S., Steinmetz, J., & Rasmussen, L. S. (2010). Methodological Issues of Postoperative Cognitive Dysfunction Research. Seminars in Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1177/1089253210371520
320. Furukawa, K., Kamada, M., Ishiki, A., Tomita, N., & Arai, H. (2014). [Clinical diagnosis].. PubMed.
321. Galanter, M. (2014). Network Therapy for Substance Use Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg60
322. Galderisi, S. (2012). W04-03 - Psychosocial functioning - relationship with symptoms and cognitive impairment. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75680-8
323. Gale, R., & Rockwood, K. (2015). Dementia/Neurocognitive Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp379
324. Gallais, B., Gagnon, C., Mathieu, J., Richer, L., Jean, S., & Laberge, L. (2014). Cognitive Deficits Associated with Sleep Apnea in Myotonic Dystrophy Type 1. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-140012
325. Gallarda, T. (2004). [Depression and organic brain diseases in the elderly].. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
326. Gallego, D., Figueroa, J., & Orozco, C. (2010). Síndrome de disfunción cognitiva de perros geriátrico. Revista Mvz Córdoba. https://doi.org/10.21897/rmvz.313
327. Gandolfi, M., Sandri, A., Mariotto, S., Tamburin, S., Paolicelli, A. M., Fiorio, M., Pedrotti, G., Barone, P., Pellecchia, M. T., Erro, R., Cuoco, S., Carotenuto, I., Vinciguerra, C., Botto, A., Zenere, L., Canu, E., Sibilla, E., Filippi, M., Sarasso, E., ... Tinazzi, M. (2024). A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders. PLoS ONE. https://doi.org/10.1371/journal.pone.0309408
328. Garcez, F. B., Avelino‐Silva, T. J., Castro, R. E. V. D., & Inouye, S. K. (2021). Delirium in older adults. Geriatrics Gerontology and Aging. https://doi.org/10.53886/gga.e0210032
329. Garcia, C. P., Sacks, S. A., & Mamani, A. G. W. D. (2012). Neurocognition and Cognitive Biases in Schizophrenia. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0b013e3182614264
330. Garcia, M. O., Garnica, M. M., Marin, S. G., Martínez, C., Martínez, R. G., & Valle, P. B. D. (2017). A child with Pica. A case presentation. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.472
331. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
332. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
333. Garrett, M., Merissa, N., & Scott, P. J. H. (2011). Diagnosis of Dementia Using Nuclear Medicine Imaging Modalities. InTech eBooks. https://doi.org/10.5772/25283
334. Garriga-Grimau, L., Laín, G. A., Nascimiento, M. T., & Aleman, A. P. (2015). Síndrome cerebeloso cognitivo-afectivo. Archivos Argentinos de Pediatria. https://doi.org/10.5546/aap.2015.e268
335. Gasquoine, P. G. (2011). Cognitive impairment in common, noncentral nervous system medical conditions of adults and the elderly. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2010.536759
336. Geddes, J. (2000). Answering clinical questions about prognosis. Evidence-Based Mental Health. https://doi.org/10.1136/ebmh.3.4.100
337. Geier, D. A., & Geier, M. R. (2015). Understanding the Importance of the Evaluation and Treatment of Elevated Androgens in Autism Spectrum Disorder. InTech eBooks. https://doi.org/10.5772/59394
338. Gelb, A. W., & Mackensen, G. B. (2004). Postoperative cognitive deficits: more questions than answers. European Journal of Anaesthesiology. https://doi.org/10.1017/s0265021504002017
339. Gelb, A. W., & Mackensen, G. B. (2004). Postoperative cognitive deficits: more questions than answers. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-200402000-00001
340. Genov, K., & Dimitrova, M. (2022). Correlation between cognitive abilities and social functioning in patients with multiple sclerosis. Folia Medica. https://doi.org/10.3897/folmed.64.e58611
341. Gentile, J. P. (2018). Aggression in Intellectual Disability. International Journal of Autism & Related Disabilities. https://doi.org/10.29011/2642-3227.000010
342. Gershanik, O. S. (2002). [Dementia and cognitive impairment in Parkinson disease].. PubMed.
343. Gerstenecker, A., Mast, B. T., Duff, K., Ferman, T. J., & Litvan, I. (2012). Executive Dysfunction Is the Primary Cognitive Impairment in Progressive Supranuclear Palsy. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acs098
344. Ghosh, A., Samanta, D., Ray, S., Roy, A., & Chakraborty, T. (2024). Application of Smart Electronics in the Prevention of Neurodevelopmental Disorders in Children. International Journal of Advancement in Life Sciences Research. https://doi.org/10.31632/ijalsr.2024.v07i04.005
345. Ghosh, S. (2015). Better understanding of etiopathology needed to develop novel treatments. Medicus.
346. Gi, S. (2011). [Neurophysiological and neurotransmitter mechanisms of behavior inhibition in normal and pathological conditions]..
347. Giannakis, N., Skondra, M., Aligianni, S., Georgiou, E., Prapiadou, S., Lentzari, I., Politis, A., Laskaris, N., & Alexopoulos, P. (2021). 200 - Neuropsychiatric symptoms influence performance of activities of daily living in symptomatic Alzheimer’s Disease. International Psychogeriatrics. https://doi.org/10.1017/s1041610221001344
348. Giannakopoulos, P., Hock, C., Wettstein, A., Schüpbach, B., & Müller‐Spahn, F. (2000). [Diagnosis and therapy of behavior disorders in dementia].. PubMed.
349. Giesbrecht, T., Lynn, S. J., Lilienfeld, S. O., & Merckelbach, H. (2008). Cognitive processes in dissociation: An analysis of core theoretical assumptions.. Psychological Bulletin. https://doi.org/10.1037/0033-2909.134.5.617
350. Gil, R. (2007). [Self-consciousness, consciousness of the other and dementias].. PubMed.
351. Gillberg, C., Fernell, E., & Minnis, H. (2013). Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations. The Scientific World JOURNAL. https://doi.org/10.1155/2013/710570
352. Ginting, D. A., Jayady, A., Habibi, M. M., Andarmoyo, S., & Irawan, A. (2020). Mental health problems in covid-19 situation. European Journal of Molecular & Clinical Medicine.
353. Gioacchino, M. D., Boscolo, P., Reale, M., Muraro, R., & Giampaolo, L. D. (2011). Work stress and innate immune response.. International Journal of Immunopathology and Pharmacology.
354. Giráldez, S. L., Fernández, Ó. V., & Iglesias, P. F. (2006). La investigación cognitiva del síndrome esquizofrénico. APUNTES DE PSICOLOGÍA. https://doi.org/10.55414/m0w4jv49
355. Godefroy, O., Barbay, M., Andriuta, D., Tir, M., & Roussel, M. (2016). Global Hypoactivity and Apathy. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_5
356. Goffard, L. J. P. (2008). Juego patológico: Una revisión bibliográfica de la ludopatía.. Psicologia.com.
357. Goldstein, D. S. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-9-200211050-00011
358. Goldstein, L. H. (2014). Control of symptoms: cognitive dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199686025.003.0008
359. Gomez, L., Fernández, A. G., & Hernandez, A. (2015). Ds 22q11.2-associated Paranoid Schizophrenia: a Case Report.. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31099-3
360. González, C. A. H., Córdoba‬‬‬‬‬‬‬‬‬‬‬‬‬, ‪. M. C., Alvear, L. A., Ramos, G., Cinepsis, & Seminec (2019). Neuropsychiatric symptoms in a patient diagnosed in adulthood with Metachromatic Leukodystrophy: Case report of low incidence and prevalence in Colombia.
361. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (II) = Contributions of psychopharmacology for the treatment of personality disorders (II: grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad = pharmacological groups employed in the treatment of the disorders of personality /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v10i2.3852
362. González, L., Nwugbana, I., Patel, R., Lombardo, M., & Korenis, P. (2015). Strategies for Effective Management of Intellectually Disabled Patients on the Psychiatric Inpatient Unit. Journal of Intellectual Disability - Diagnosis and Treatment. https://doi.org/10.6000/2292-2598.2015.03.02.7
363. Gonçalves, M. R. R., Capelli, L., Nitríni, R., Barbosa, E. R., Porto, C. S., Lucato, L. T., & Vianna‐Morgante, A. M. (2007). ATYPICAL CLINICAL COURSE OF FXTAS: RAPIDLY PROGRESSIVE DEMENTIA AS THE MAJOR SYMPTOM. Neurology. https://doi.org/10.1212/01.wnl.0000262058.68100.ea
364. Gorgievski, V. (2013). Étude des déficits de la fonction exécutive dans un modèle animal hyperdopaminergique de la schizophrénie.
365. Gorre, V. N., Upadhyay, D. K., Shrivastava, B., & Kumar, K. R. (2023). A REVIEW ON COGNITIVE IMPAIRMENT AND QUALITY OF LIFE, MEDICATION ADHERENCE AND THE PRESCRIPTION PATTERN FOR SCHIZOPHRENIA. European Chemical Bulletin. https://doi.org/10.48047/ecb/2023.12.1.327
366. Goschke, T. (2013). Dysfunctions of decision‐making and cognitive control as transdiagnostic mechanisms of mental disorders: advances, gaps, and needs in current research. International Journal of Methods in Psychiatric Research. https://doi.org/10.1002/mpr.1410
367. Greden, J. F. (2003). Physical symptoms of depression: unmet needs.. PubMed.
368. Green, T. (2003). Stroke: A brain attack!.
369. Grieco, J. A., Pulsifer, M. B., Seligsohn, K., Skotko, B. G., & Schwartz, A. (2015). Down syndrome: Cognitive and behavioral functioning across the lifespan. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.31439
370. Griffiths, R., & Jones, C. (2007). Delirium, cognitive dysfunction and posttraumatic stress disorder. Current Opinion in Anaesthesiology. https://doi.org/10.1097/aco.0b013e3280803d4b
371. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
372. Guaita, A. (2011). A “Prosthetic” Approach for Individuals With Dementia?. JAMA. https://doi.org/10.1001/jama.2011.28
373. Guedes, R., Silveira, C., Maia, D., Curral, R., & Coelho, R. (2019). Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investigation. https://doi.org/10.30773/pi.2019.0106
374. Guerrero‐Berroa, E., Ravona‐Springer, R., Heymann, A., Schmeidler, J., Silverman, J. M., Sano, M., Koifmann, K., Preiss, R., Hoffman, H., & Beeri, M. S. (2014). Decreased Motor Function Is Associated with Poorer Cognitive Function in Elderly with Type 2 Diabetes. Dementia and Geriatric Cognitive Disorders Extra. https://doi.org/10.1159/000360280
375. Guerrini, R., & Falchi, M. (2011). Dravet syndrome and <i>SCN1A</i> gene mutation related‐epilepsies: cognitive impairment and its determinants. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.03966.x
376. Gupta, T., Strauss, G. P., Cowan, H. R., Pelletier‐Baldelli, A., Ellman, L. M., Schiffman, J., & Mittal, V. A. (2021). Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome. Biological Psychiatry Global Open Science. https://doi.org/10.1016/j.bpsgos.2021.05.008
377. Gur, R. C., Moelter, S. T., & Ragland, J. D. (2000). Learning and memory in schizophrenia. https://doi.org/10.1093/oso/9780192629937.003.0004
378. Gur, R. C., Ragland, J. D., & Gur, R. E. (1997). Cognitive changes in schizophrenia-a critical look. International Review of Psychiatry. https://doi.org/10.1080/09540269775312
379. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
380. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
381. Guthrie, T. R. (2021). Other Health Impairment (OHI) Disabilities Category and an In-Depth Look at the Most Common Neurobiological Condition for Students. Advances in higher education and professional development book series. https://doi.org/10.4018/978-1-7998-7359-4.ch003
382. Gélinas, C., Klein, K., Naidech, A., & Skrobik, Y. (2013). Pain, Sedation, and Delirium Management in the Neurocritically Ill: Lessons Learned from Recent Research. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/s-0033-1342986
383. Haan, E. H. D., Nys, G., & Zandvoort, M. J. V. (2006). Cognitive function following stroke and vascular cognitive impairment. Current Opinion in Neurology. https://doi.org/10.1097/01.wco.0000247612.21235.d9
384. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
385. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
386. Halbauer, J. D., Ashford, J. W., Zeitzer, J. M., Adamson, M. M., Lew, H. L., & Yesavage, J. A. (2009). Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. The Journal of Rehabilitation Research and Development. https://doi.org/10.1682/jrrd.2008.08.0119
387. Halicka, D., Jankowicz, E., & Paprocka, K. (1998). [Subcortical dementia and the frontal lobe syndrome].. PubMed.
388. Hamed, S. A. (2014). Diabetes mellitus and the brain : special emphasis on cognitive function : review. The South African journal of diabetes & vascular disease.
389. Hanken, K., Eling, P., & Hildebrandt, H. (2014). Is there a cognitive signature for MS-related fatigue?. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458514549567
390. Hanyu, H. (2011). 1. Early Diagnosis of Dementia, Including MCI.. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.100.2109
391. Hao, Y., Controzzi, M., Cipriani, C., Popović, D. B., Yang, X., Chen, W., Zheng, X., & Carrozza, M. C. (2013). Controlling hand-assistive devices: utilizing electrooculography as a substitute for vision. IEEE Robotics & Automation Magazine. https://doi.org/10.1109/mra.2012.2229949
392. Haonat, G. A. F. I., Rezende, L. A. D., Paiva, L. F. D. A., Miranda, L. A., Rubião, A. L. N., Castro, B. B. M. D., Nogueira, L. H. F., Teixeira, B. G., Lima, J. M. P., Feital, V. E., Oliveira, N. B. D., Medicina, R. S. D. C., Marily, S. S. A., Nunes, H. T. S., Azevedo, M. E. C. D., & Nicoli, H. F. (2024). DEMÊNCIA E TRANSTORNOS COGNITIVOS EM IDOSOS. Brazilian Journal of Implantology and Health Sciences. https://doi.org/10.36557/2674-8169.2024v6n5p648-656
393. Harding, S. (2005). Continuing Professional Development Managing delirium in older people.
394. Harrington, E., Gamaldo, A., Felt, J. M., Witzel, D., Sliwinski, M. J., Murdock, K. W., Engeland, C. G., & Graham‐Engeland, J. E. (2024). Racial differences in links between perceived discrimination, depressive symptoms, and ambulatory working memory. Aging & Mental Health. https://doi.org/10.1080/13607863.2024.2351923
395. Harvey, A. G., & Tang, N. K. Y. (2011). (Mis)perception of sleep in insomnia: A puzzle and a resolution.. Psychological Bulletin. https://doi.org/10.1037/a0025730
396. Harvey, P. D. (2010). Cognitive Functioning and Disability in Schizophrenia. Current Directions in Psychological Science. https://doi.org/10.1177/0963721410378033
397. Harvey, P. D., & Pinkham, A. E. (2015). Impaired Self-Assessment in Schizophrenia: Why Patients Misjudge Their Cognition and Functioning: Observations from Caregivers and Clinicians Seem to Have the Most Validity. Current psychiatry.
398. Hausteiner‐Wiehle, C. (2022). Funktionelle Körperbeschwerden: Klinische Vielfalt, diagnostische Herausforderungen, therapeutische Prinzipien. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/a-1554-1662
399. HEC, M. (2021). The Impact of Preeclampsia on Work-Related Psychosocial Aspects and Need for Recovery. Reproductive Medicine Gynaecology & Obstetrics. https://doi.org/10.24966/rmgo-2574/100080
400. Heilman, K. M., Watson, R. T., & Valenstein, E. (2003). Neglect and Related Disorders. https://doi.org/10.1093/oso/9780195133677.003.0013
401. Hemmeter, U.-M., Thum, N., Hemmeter-Spernal, U., Pd, M., Psychiatrische, K., & St, D. (2011). Schlafstörungen im Alter. Schweizer Archiv für Neurologie und Psychiatrie. https://doi.org/10.4414/sanp.2011.02254
402. Henry, L. A., Messer, D., & Poloczek, S. (2018). Working Memory and intellectual disabilities. Routledge eBooks. https://doi.org/10.4324/9781315302072-2
403. Hepsiba, & Raju, M. V. R. (2017). Intellectual Disability. International Research Journal of Engineering IT & Scientific Research. https://doi.org/10.21744/irjeis.v3i5.532
404. Herika, S. E., Ferran, P. B., & Patricia, M.-M. M. (2012). Un caso de deterioro cognitivo, personal y social; en los niveles más bajos de funcionamiento.
405. Hernández, C. D. L. (2022). Dislexia: manifestaciones socioemocionales en el trastorno de aprendizaje y su intervención multidisciplinar. Ciencia y Academia. https://doi.org/10.21501/2744838x.4486
406. Hernández, J. V., Robledo, M. E. B., González, C. A. H., Escobar, C. S. M., Otalvaro, S. O., Tobón, J. D. S., Pava, P. M. A. D. L., & Criado‐Álvarez, J. J. (2021). Neuropsychiatric Aspects in a Patient Diagnosed with Frontotemporal Dementia: Clinical Case of Low Incidence and Prevalence Disease in Colombia. Case Reports in Neurology. https://doi.org/10.1159/000513851
407. Heslop, K. (2012). Binocular rivalry and visuospatial ability in individuals with schizophrenia. Faculty of Health.
408. Hinckley, J. (2009). Clinical Decision-Making for Stroke and Aphasia in the Older Adult. Perspectives on Gerontology. https://doi.org/10.1044/gero14.1.4
409. Hindmarch, I. (1998). The behavioural toxicity of antidepressants. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199807006-00002
410. Hiro, H., & Nagata, M. (2015). Support of workers with Developmental Disorders. Stress Science Research. https://doi.org/10.5058/stresskagakukenkyu.30.35
411. Hodges, J. R. (2010). Alzheimer’s disease and other dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.2442
412. Hodges, J. R., & Graham, K. S. (2002). Episodic memory: insights from semantic dementia. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198508809.003.0008
413. Hoff, A. L., & Kremen, W. S. (2002). Is there a cognitive phenotype for schizophrenia: the nature and course of the disturbance in cognition?. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-200201000-00008
414. Hopkins, R. O., & Brett, S. J. (2005). Chronic neurocognitive effects of critical illness. Current Opinion in Critical Care. https://doi.org/10.1097/01.ccx.0000166399.88635.a5
415. Hopkins, R. O., & Jackson, J. C. (2016). Neurocognitive impairment after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199600830.003.0382
416. Horn, J. B., Zandbergen, E., Koelman, J., & Hijdra, A. (2008). Prognosis for patients in a coma following cardiopulmonary resuscitation.
417. Hosseinbor, N., & Bakhshani, N.-M. (2014). Djinnati Syndrome in Baluchistan: The Role of Traumatic and Abuse Experiences on Individual Vulnerability. international journal high risk behaviors & addiction. https://doi.org/10.5812/ijhrba.23610
418. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/cphy.c130045
419. Hou, S., & Rabchevsky, A. G. (2014). Autonomic Consequences of Spinal Cord Injury. Comprehensive physiology. https://doi.org/10.1002/j.2040-4603.2014.tb00584.x
420. Howard, R., Tan, S. V., & Z’Graggen, W. J. (2008). Weakness on the intensive care unit. Practical Neurology. https://doi.org/10.1136/jnnp.2008.157263
421. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
422. HumpHreyS, S. (2013). The Aging Physician.
423. Huron, C. (2017). Developmental Coordination Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n425
424. Hurvitz, E. A., Whitney, D. G., Waldron‐Perrine, B., Ryan, D., Haapala, H., Schmidt, M., Gray, C., & Peterson, M. D. (2021). Navigating the Pathway to Care in Adults With Cerebral Palsy. Frontiers in Neurology. https://doi.org/10.3389/fneur.2021.734139
425. Hustig, H., & Norrie, P. (1998). MJA practice essentials. Managing schizophrenia in the community.. PubMed.
426. Hwang, H., Na, K., Kim, S. G., Lee, S. I., & Jung, H. (2012). Alteration of Cognitive Function in Mild Traumatic Brain Injury Patients Grouped by Subjective Depression. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2012.51.5.300
427. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
428. Hylin, M. J., Orsi, S. A., Rozas, N. S., Hill, J. L., Zhao, J., Redell, J. B., Moore, A. N., & Dash, P. K. (2013). Repeated Mild Closed Head Injury Impairs Short-Term Visuospatial Memory and Complex Learning. Journal of Neurotrauma. https://doi.org/10.1089/neu.2012.2717
429. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
430. Iam, M., & Jansen, J. (2000). Psychische (on)gezondheid; determinanten en de effecten van preventieve interventies.
431. Ibrahim, I. R., & Amar, K. (2007). Mild cognitive impairment. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2007.68.10.27322
432. Ibrahim, J., Anderson, L., MacPhail, A., Lovell, J., Davis, M., & Winbolt, M. (2017). Chronic disease self-management support for persons with dementia, in a clinical setting. Journal of Multidisciplinary Healthcare. https://doi.org/10.2147/jmdh.s121626
433. Idiazábal-Aletxa, M. A., & Saperas-Rodríguez, M. (2008). [Auditory processing in specific language disorder].. PubMed.
434. Ikeda, M. (2015). Communication difficulties in patients with neurodegenerative dementia. Higher Brain Function Research. https://doi.org/10.2496/hbfr.35.292
435. Iliffe, S., & Pealing, L. (2010). Subjective memory problems. BMJ. https://doi.org/10.1136/bmj.c1425
436. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
437. Inmaculada, M., & Pérez, P. B. (2016). Neuronal and behavioural effects of social isolation in old age.
438. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
439. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
440. Iwasaki, Y., Kinoshita, M., Ikeda, K., & Takamiya, K. (1989). Cognitive Function in Multiple Sclerosis and its Relation to Functional Abilities. International Journal of Neuroscience. https://doi.org/10.3109/00207458909002163
441. Jain, A. A. (2021). Narcolepsy: A Chronic Neurological Disorder - A Review. Bioscience Biotechnology Research Communications. https://doi.org/10.21786/bbrc/14.6.61
442. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
443. Jain, S., Kothari, S., Rohith, V. S., Kumar, H., & Jain, C. (2024). The Relationship Between Auditory and Cognitive Processing Abilities in Children With Specific Learning Disorders. American Journal of Audiology. https://doi.org/10.1044/2024_aja-24-00001
444. Jak, H. J. O. A. J., ColÃ, A. M. G. C. C., Drummond, D. M. S. S. P., & Twamley, J. B. L. E. W. (2015). Sleep Disturbance, Psychiatric, and Cognitive Functioning in Veterans with Mild to Moderate Traumatic Brain Injury. Journal of Sleep Disorders Treatment & Care. https://doi.org/10.4172/2325-9639.1000153
445. Jason, L. A., King, C., Taylor, R. R., & Kennedy, C. L. (2000). Defining Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v07n03_03
446. Jellinger, K. A. (2000). Morphological substrates of mental dysfunction in Lewy body disease: an update. https://doi.org/10.1007/978-3-7091-6781-6_21
447. Jimenez, B., & Lechuga, Y. A. (2019). La importancia del sueño en la vida cotidiana.
448. Jiménez-Marín, A., Rivera, D., Boado, V., Díez, I., Labayen, F., Garrido, I., Ramos‐Usuga, D., Rasero, J., Cabrera, A., Stramaglia, S., Arango‐Lasprilla, J. C., & Cortés, J. M. (2018). Hyperconnectivity of the default mode network in multiorgan dysfunction syndrome. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/418160
449. Johnson, B. (2016). Early Intervention in Children with Developmental Disabilities.
450. Johnson, J. K. (2009). Mild cognitive impairment subgroups. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581410.014
451. Johnson, T. V., & Rovner, B. W. (2014). Disablement-Based Nomenclature for Vision and Function. JAMA Ophthalmology. https://doi.org/10.1001/jamaophthalmol.2014.154
452. Jones, G. E., Drake, C., & Lewis, C. F. (2022). Explanations Underlying the Lack of Utility of Diagnostic Depression Scales in Black Americans. Psychiatric Annals. https://doi.org/10.3928/00485713-20221206-02
453. Jones, M. W. (2010). Errant ensembles: dysfunctional neuronal network dynamics in schizophrenia. Biochemical Society Transactions. https://doi.org/10.1042/bst0380516
454. Jones, S., Howard, L. M., & Thornicroft, G. (2008). ‘Diagnostic overshadowing’: worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.2008.01211.x
455. Joyce, E. M., Hutton, S., Mutsatsa, S., & Barnes, T. R. E. (2005). Cognitive heterogeneity in first-episode schizophrenia. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.187.6.516
456. Jun, L., Huang, K., Zhu, B., Zhou, B., Harb, A. K. A., Liu, L., & Wu, X. (2021). Neuropsychological Tests in Post-operative Cognitive Dysfunction: Methods and Applications. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.684307
457. Juva, K. (2013). [Assessment of legal functional capacity of a neuropsychiatric patient].. PubMed.
458. Juva, K. (2014). [Incipient cognitive disorder--when does concern of memory impairment direct to comprehensive examinations?].. PubMed.
459. Kabel, A. M., & Maghrabi, I. A. (2014). Sleep and its disorders. El Mednifico Journal. https://doi.org/10.18035/emj.v2i4.255
460. Kadkol, M. S. (2013). A Case Review of Perceptual Deficit in PRES: Detailed Perceptual Evaluation is a Key to Definite Goal Achieving Techniques. Indian Journal of Physiotherapy and Occupational Therapy - An International Journal. https://doi.org/10.5958/j.0973-5674.7.3.078
461. Kahler, S. G., & Fahey, M. (2003). Metabolic disorders and mental retardation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.10018
462. Kalogerakis, M. G. (1992). Emergency Evaluation of Adolescents. Psychiatric Services. https://doi.org/10.1176/ps.43.6.617
463. Kane, J. M., & Mayerhoff, D. (1989). Do Negative Symptoms Respond to Pharmacological Treatment?. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000291630
464. Kapoor, I., Prabhakar, H., & Mahajan, C. (2019). Postoperative Cognitive Dysfunction. Indian Journal of Critical Care Medicine. https://doi.org/10.5005/jp-journals-10071-23196
465. Kapp, M. B. (2016). Legal issues in dementia. CRC Press eBooks. https://doi.org/10.3109/9781420020250-13
466. Kaprinis, G., Fountoulakis, K. Ν., & Kaprinis, S. (2002). Arguments against the Cognitive Dysmetria Hypothesis of Schizophrenia. Perceptual and Motor Skills. https://doi.org/10.2466/pms.2002.94.3.975
467. Kar, S. K., & Jain, M. (2016). Current understandings about cognition and the neurobiological correlates in schizophrenia. Journal of Neurosciences in Rural Practice. https://doi.org/10.4103/0976-3147.176185
468. Kar, S. K., & Singh, A. (2022). Noninvasive Brain Stimulation for Cognitive Impairment in Schizophrenia. Annals of Indian Psychiatry. https://doi.org/10.4103/aip.aip_105_22
469. Karyakina, M., & Rychkova, O. (2021). Cognitive impairments in schizophrenia in foreign studies: single function deficits or group of syndromes?. Journal of Modern Foreign Psychology. https://doi.org/10.17759/jmfp.2021100201
470. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
471. Katiri, R., Hall, D. A., & Kitterick, P. T. (2020). Developing an International Core Outcome Set for SSD Interventions. The Hearing Journal. https://doi.org/10.1097/01.hj.0000661612.83232.57
472. Katz, P. (2006). Function, Disability, and Psychological Well-Being. KARGER eBooks. https://doi.org/10.1159/000095365
473. Kaufmann, L., & Aster, M. V. (2012). The Diagnosis and Management of Dyscalculia. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2012.0767
474. Kavanagh, P. L., & Marder, K. (2012). Dementia. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-429-6_4
475. Kavanaugh, B. C., Dupont-Frechette, J. A., Jerskey, B. A., & Holler, K. (2016). Neurocognitive deficits in children and adolescents following maltreatment: Neurodevelopmental consequences and neuropsychological implications of traumatic stress. Applied Neuropsychology Child. https://doi.org/10.1080/21622965.2015.1079712
476. Kawamura, M. (2011). Social cognitive impairment is an integral part of Parkinson disease. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.51.1
477. Kałwa, A. (2012). [Cognitive dysfunctions in bipolar disorders].. PubMed.
478. Keefe, R. S., & Fenton, W. S. (2007). How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment?. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbm046
479. Keller, A. S., Leikauf, J. E., Holt-Gosselin, B., Staveland, B. R., & Williams, L. M. (2019). Paying attention to attention in depression. Translational Psychiatry. https://doi.org/10.1038/s41398-019-0616-1
480. Kennedy, G. J., Onuogu, E., & Lowinger, R. J. (1999). Psychiatric emergencies: rapid response and life-saving therapies.. PubMed.
481. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
482. Kenny, P., Barfield, D., & Malík, R. (2018). Lower Motor Neuron Disease. https://doi.org/10.1002/9781119028994.ch27
483. Kerber, A., Beintner, I., Burchert, S., & Knaevelsrud, C. (2021). Does app-based unguided self-management improve mental health literacy, patient empowerment and access to care for people with mental health impairments? Study protocol for a randomised controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2021-049688
484. Kerchner, G. A., & Rosenbloom, M. (2014). Frontotemporal Neurocognitive Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg65
485. Kessels, R. P. C., & Savage, G. (2015). Amnestic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp060
486. Kessler, J., Markowitsch, H. J., Huber, M., Kalbe, E., Weber‐Luxenburger, G., & Kock, P. (1997). Massive and persistent anterograde amnesia in the absence of detectable brain damage: Anterograde psychogenic amnesia or gross reduction in sustained effort?. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/01688639708403746
487. Kessler, R., Ford, L., Cram, A., & Pontón, M. O. (2014). C-28 * Psychosis, Epilepsy, and Brain Damage: A Neuropsychological Evaluation Case Study. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acu038.209
488. Khan, I., & Khan, M. A. (2021). Sensory and Perceptual Alterations. StatPearls.
489. Kinder, R. (2014). Coding for Mild Cognitive Impairment. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.72
490. King, B. H. (2001). Psychopharmacology in intellectual disabilities. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543616.020
491. Kinney, M., & Craig, J. (2015). Grand Rounds: An Update on Convulsive Status Epilepticus.. PubMed.
492. Kirshbaum, M. (2011). Pharmacologic Treatments for Fatigue Associated With Palliative Care. Clinical journal of oncology nursing. https://doi.org/10.1188/11.cjon.438-439
493. Kish, S. J., & Hornykiewicz, O. (1984). Neurochemical Basis of Dementia in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046382
494. Klein, S. D., Shekels, L. L., McGuire, K. A., & Sponheim, S. R. (2020). Neural Anomalies during Vigilance in Schizophrenia: Diagnostic Specificity and Genetic Associations. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.04.03.20052100
495. Klimkeit, E., Tonge, B. J., Bradshaw, J. L., Melvin, G., & Gould, K. R. (2011). Neuropsychological Deficits in Adolescent Unipolar Depression. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acr051
496. Klonoff, P. S., Lamb, D. G., & Henderson, S. W. (1999). Productivity of patients with brain injuries up to 11 years post-discharge from milieu-based Rehabilitation. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/14.1.151a
497. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
498. Knight, M. J., Mills, N., & Baune, B. T. (2019). Contemporary methods of improving cognitive dysfunction in clinical depression. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2019.1610395
499. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1336
500. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
501. Knupp, K. G., & Wirrell, E. (2014). Progressive myoclonic epilepsies. Neurology. https://doi.org/10.1212/wnl.0000000000000091
502. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
503. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
504. Kopach, O., & Pivneva, T. (2018). Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration: neurophysiological insights into stem progenitor cell neurogenesis within a host environment. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.235224
505. Kopf, T., Galić, S., & Matešić, K. (2016). The Efficiency of MMPI-2 Validity Scales in Detecting Malingering of Mixed Anxiety-Depressive Disorder.
506. Koster, S., Hensens, A. G., Schuurmans, M. J., & Palen, J. V. D. (2011). Consequences of Delirium After Cardiac Operations. The Annals of Thoracic Surgery. https://doi.org/10.1016/j.athoracsur.2011.07.006
507. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
508. Kotowicz, K., Gawęda, Ł., Misiak, B., & Frydecka, D. (2020). The role of the cognitive biases along the psychosis continuum: from pathophysiology to treatment options. Archives of Psychiatry and Psychotherapy. https://doi.org/10.12740/app/130365
509. Kramer, J. H., & Delis, D. C. (1998). Neuropsychological Assessment of Memory. Neuropsychology. https://doi.org/10.1007/978-1-4899-1950-2_16
510. Kraus, J., Lohmann, H., & Evers, S. (2008). Kognitives Defizit als gutachterlich relevantes, nicht erkanntes Syndrom infolge von Multipler Sklerose. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0028-1100835
511. Krieger, J. E. (2000). Clinical approach to excessive daytime sleepiness.. PubMed.
512. Krupińska-Dulembal, A., Paradowski, B., Chojdak-Łukasiewicz, J., & Bladowska, J. (2014). [Cognitive impairment in multiple sclerosis].. PubMed.
513. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
514. Krägeloh‐Mann, I. (2010). Clinical outcome: neurological sequelae following preterm birth. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511712166.004
515. Kuiper, J. S. (2016). The importance of social relationships in the process of cognitive ageing.
516. Kumar, M., & Bansal, N. (2021). A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease. Current Drug Targets. https://doi.org/10.2174/1389450122666211118125233
517. Kumar, S., & Flemming, K. D. (2021). Syndromes of Cognitive Dysfunction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0076
518. Kuzis, G., Sabe, L., Tiberti, C., Leiguarda, R., & Starkstein, S. E. (1997). Cognitive Functions in Major Depression and Parkinson Disease. Archives of Neurology. https://doi.org/10.1001/archneur.1997.00550200046009
519. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
520. Lacassie, Y., Bobadilla, O., & Cambias, R. D. (1997). A boy with a mild case of Cornelia de Lange syndrome with above average intelligence. Journal of Intellectual & Developmental Disability. https://doi.org/10.1080/13668259700033511
521. Lago, S., Bevilacqua, F., Stabile, M., Scarpazza, C., Bambini, V., & Arcara, G. (2022). Case report: Pragmatic impairment in Multiple Sclerosis after worsening of clinical symptoms. https://doi.org/10.31234/osf.io/6v5em
522. Lam, R. W. (2018). Associated clinical features. Depression. https://doi.org/10.1093/med/9780198804147.003.0005
523. Lam, R. W. (2018). Clinical features and diagnosis. Depression. https://doi.org/10.1093/med/9780198804147.003.0004
524. Landau, W. (2011). ‘Causal relation between spasticity, strength, gross motor function, and functional outcome in children with cerebral palsy: a path analysis’. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04006.x
525. Langdon, R., Michie, P. T., Ward, P. B., McConaghy, N., Catts, S. V., & Coltheart, M. (1997). Defective Self and/or Other Mentalising in Schizophrenia: A Cognitive Neuropsychological Approach. Cognitive Neuropsychiatry. https://doi.org/10.1080/135468097396324
526. Lanska, D. J. (2006). Functional Weakness and Sensory Loss. Seminars in Neurology. https://doi.org/10.1055/s-2006-945516
527. Lanska, D. J. (2014). Disorders of the Special Senses in the Elderly. https://doi.org/10.1002/9781118730676.ch17
528. Lara, E. (2017). Deterioro cognitivo leve y reserva cognitiva en una muestra representativa de la población española.
529. Lara-Plaza, O., Solís‐Navarro, L., Rivera‐Lillo, G., & Torres‐Castro, R. (2022). Cognitive and motor performance effects of non-invasive brain stimulation in patients with traumatic brain injury: A meta-analysis of randomised controlled trials. https://doi.org/10.37766/inplasy2022.4.0067
530. Latas, M. (2014). Cognitive-behavior treatment of insomnia. Engrami. https://doi.org/10.5937/engrami1402051l
531. Latronico, N., Antonini, L., Taricco, M., Vignolo, L., & Candiani, A. (2000). [Approach to the patient in vegetative state. Part II: differential diagnosis].. PubMed.
532. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
533. Lawson, W., & Dombroski, B. A. (2017). Problems with Object Permanence: Rethinking Traditional Beliefs Associated with Poor Theory of Mind in Autism. Journal of Intellectual Disability - Diagnosis and Treatment. https://doi.org/10.6000/2292-2598.2017.05.01.1
534. Lazare, A. (2021). Psychiatry. Routledge eBooks. https://doi.org/10.4324/9781003261599-25
535. Lee, S. G., & Kim, Y. R. (2015). Effect of Dual Task Training in Visual Control and Unstable Base on the Gait of Stroke Patient. Journal of international academy of physical therapy research. https://doi.org/10.5854/jiaptr.2015.03.31.788
536. Lee‐Chiong, T. (2008). Insomnia. https://doi.org/10.1093/oso/9780195306590.003.0003
537. Lee‐Chiong, T. (2008). Medications and Their Effects on Sleep. https://doi.org/10.1093/oso/9780195306590.003.0016
538. Lee‐Chiong, T. (2008). Psychiatric and Behavioral Disorders. https://doi.org/10.1093/oso/9780195306590.003.0011
539. Lee‐Chiong, T. (2008). Sleep in Neurologic Disorders. https://doi.org/10.1093/oso/9780195306590.003.0010
540. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
541. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
542. Leung, M., Thompson, B., Black, J., Dai, S., & Alsweiler, J. M. (2017). The effects of preterm birth on visual development. Clinical and Experimental Optometry. https://doi.org/10.1111/cxo.12578
543. Levi, L., Ballon, J. S., & Kantrowitz, J. T. (2013). Investigational Treatments for Cognitive Impairment in Schizophrenia: The Authors Examine the Landscape of Drug and Nondrug Therapies under Active Investigation for Cognitive Impairment in Schizophrenia. Current psychiatry.
544. Levin, B., Tomer, R., & Rey, G. (1992). Cognitive Impairments in Parkinson’s Disease. Neurologic Clinics. https://doi.org/10.1016/s0733-8619(18)30222-6
545. Levy, J. A., & Chelune, G. J. (2007). Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988707308806
546. León, M. S. M. D. (2017). Trastorno por déficit de atención con hiperactividad: autorregulación emocional y funciones ejecutivas.
547. LEÓN-CARRIÓN, M. D. R. D. M. J. (2006). Low-level responsive states. Taylor & Francis eBooks. https://doi.org/10.4324/9780203965238-15
548. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
549. Leśniak, M., Bak, T. H., Czepiel, W., Seniów, J., & Członkowska, A. (2008). Frequency and Prognostic Value of Cognitive Disorders in Stroke Patients. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000162262
550. Lichtman, E., & Frager, N. S. (2020). Pain and Cognition: A Narrative Review of the Effects of Chronic Pain on Neuropsychological Functioning. https://doi.org/10.14293/s2199-1006.1.sor-.ppn658z.v1
551. Liddle, P. F. (1987). Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine. https://doi.org/10.1017/s0033291700012976
552. Lidzba, K. (2022). Cerebral Palsy From a Developmental Psychology Perspective. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.114
553. Ligier, F., & Kabuth, B. (2016). Between Neurology and Psychiatry, a Difficult Preliminary Diagnosis of Kleine-levin Syndrome: Case-report of a Young Girl. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000274
554. Liu‐Ambrose, T., Nagamatsu, L. S., Handy, T. C., & Leghari, A. (2008). DOES IMPAIRED CEREBELLAR FUNCTION CONTRIBUTE TO RISK OF FALLS IN SENIORS? A PILOT STUDY USING FUNCTIONAL MAGNETIC RESONANCE IMAGING. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2008.01984.x
555. Loitman, J. E., & Deshields, T. L. (2010). Psychiatric Palliative Care Issues. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-590-3_4
556. Loock, C., Chudley, A. E., Conry, J., Cook, J. L., Rosales, T., & LeBlanc, N. J. (2005). Correction. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.051283
557. Love, M., & Geldmacher, D. (2018). Alzheimer’s Disease. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy20
558. Luisetto, M. (2018). Mindset kinetics and Some Depression Status: A New Quantitative Model Under Biochemical-Toxicology Approach?. Journal of pharmacology & clinical research. https://doi.org/10.19080/jpcr.2018.05.555680
559. Lévy, R., & Pillon, B. (2006). [Cognitive disorders in Parkinson's disease without dementia].. PubMed.
560. López, A., & Lourdes, M. D. (2018). Traumatismo craneoencefalico moderado.
561. M.E., B., VergelHernández, J., C.A., H., C.S., M., Ospina-Otálvaro, S., J.D., S., P.M., A., J.J., A., Basic, A. C. N. S. R. T. O., & Psychiatry, S. O. M. R. T. O. (2021). Supplementary Material for: Neuropsychiatric Aspects in a Patient Diagnosed with Frontotemporal Dementia: Clinical Case of Low Incidence and Prevalence Disease in Colombia. Figshare. https://doi.org/10.6084/m9.figshare.14932008
562. MacLullich, A. M. J., Marcantonio, E. R., & Meagher, D. (2017). Delirium. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198701590.003.0049
563. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
564. MacQueen, G., & Young, T. M. (2003). Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disorders. https://doi.org/10.1111/j.1399-2406.2003.00059.x
565. Maeshima, S., Osawa, A., & Tanahashi, N. (2012). Assessment of cognitive impairment due to frontal lobe damage. Higher Brain Function Research. https://doi.org/10.2496/hbfr.32.21
566. Maestú, F., Matía‐Martín, P., Sola, R. G., & Ortiz, T. (1999). Neuropsicología y deterioro cognitivo en la epilepsia. Revista de Neurología. https://doi.org/10.33588/rn.2808.98915
567. Maetzler, W. (2014). Comment: Why do nondopaminergic features in Parkinson disease matter?. Neurology. https://doi.org/10.1212/wnl.0000000000000095
568. Magallón, S., & Narbona, J. (2009). [Detection and specific studies in procedural learning difficulties].. PubMed.
569. Magnante, A. T., Ord, A. S., Holland, J., & Sautter, S. W. (2022). Neurocognitive functioning of patients with early-stage Parkinson’s disease. Applied Neuropsychology Adult. https://doi.org/10.1080/23279095.2022.2106865
570. Mah, L., Murari, G., Vandermorris, S., Verhoeff, N. P. L., & Herrmann, N. (2021). Characterizing the phenomenology of anxiety in older adults with subjective cognitive decline. Alzheimer s & Dementia. https://doi.org/10.1002/alz.055815
571. Mahon, S. M., & Carr, E. (2021). Cognitive Dysfunction: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.23
572. Malaty, J., & Malaty, I. A. (2013). Smell and taste disorders in primary care.. PubMed.
573. Maldonado, J. R., & Spiegel, D. (2015). Dissociative Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch61
574. Malek, N., & Greene, J. (2014). Cognition enhancers for the treatment of dementia. Scottish Medical Journal. https://doi.org/10.1177/0036933014561948
575. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
576. Manning, K. J., & Wolfson, L. (2017). Decreasing Fall Risk: Intensive Cognitive Training and Blood Pressure Control. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.14896
577. Manohar, S., Bonnelle, V., & Husain, M. (2014). Neurological Disorders of Attention. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199675111.013.027
578. Manso-Calderón, R., & Sevillano-García, M. D. (2010). [Nonmotor symptoms in Parkinson's disease and deep brain stimulation].. Revista de Neurología.
579. Manwell, L., Tadros, M., Ciccarelli, T. M., & Eikelboom, R. (2022). Digital dementia in the internet generation: excessive screen time during brain development will increase the risk of Alzheimer's disease and related dementias in adulthood. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2101028
580. Manzo-García, D. M., & Alvarez-Bobadilla, G. M. (2010). Evaluación del estado de conciencia con la prueba de Folstein, en pacientes bajo anestesia general, sometidos a cirugía de columna. Deleted Journal.
581. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
582. Marcone, S. (2018). La mémoire prospective dans le trouble cognitif léger avec ou sans trouble comportemental en sommeil paradoxal.
583. Marek, G. J. (2011). CASE STUDIES IN NEUROSCIENCE: UNIQUE CHALLENGES AND EXAMPLES. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511976087.008
584. Marillier, M. (2017). Altérations cérébrales associées à l'hypoxie et au syndrome d'apnées obstructives du sommeil à l'exercice.
585. Marino, S., Ciurleo, R., Baglieri, A., Corallo, F., De, R., De, S., Guerrera, S., Timpano, F., Bramanti, P., & Nicola, S. D. (2012). Neuroimaging and Outcome Assessment in Vegetative and Minimally Conscious State. InTech eBooks. https://doi.org/10.5772/23003
586. Markousis‐Mavrogenis, G., Bacopoulou, F., Kolovou, G., Pons, M.-R., Giannakopoulou, A., Papavasiliou, A., Kitas, G. D., Chrousos, G. P., & Mavrogeni, S. (2022). Pathophysiology of cognitive dysfunction and the role of combined brain/heart magnetic resonance imaging (Review). Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2022.11506
587. Marks, D. J., Trampush, J. W., & Chacko, A. (2010). Attention deficit hyperactivity disorder in children and adolescents. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511674815.008
588. Marsh, D. T. (2005). Serious Emotional Disturbance and Serious Mental Illness. https://doi.org/10.1093/oso/9780195162035.003.0008
589. Martinez-Assucena, A., Marnetoft, S., Rovira, T. R., Miguel, H. S., Bernabeu, M., & Martinell-Gispert-Sauch, M. (2010). Rehabilitation for Multiple Sclerosis in Adults (I); Impairment and Impact on Functioning and Quality of Life: An Overview. Critical Reviews in Physical and Rehabilitation Medicine. https://doi.org/10.1615/critrevphysrehabilmed.v22.i1-4.90
590. Martini, A., Castiglione, A., Bovo, R., Vallesi, A., & Gabelli, C. (2014). Aging, Cognitive Load, Dementia and Hearing Loss. Audiology and Neurotology. https://doi.org/10.1159/000371593
591. Martins, M. B., Boff, C., & Ávila, C. T. (2021). Desafios da avaliação neuropsicológica: depressão x declínio cognitivo na pessoa idosa / Neuropsychological assessment: depression versus cognitive decline in the elderly. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n5-408
592. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
593. Martínez, V. M. (2008). Estudio comparativo de las alteraciones cognitivas de un grupo de adultos jóvenes diagnosticados de hipotiroidismo subclínico frente a un grupo de individuos control.
594. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
595. Martínez‐Horta, S., Pagonabarraga, J., Bobadilla, R. F. D., García‐Sánchez, C., & Kulisevsky, J. (2013). Apathy in Parkinson's Disease: More Than Just Executive Dysfunction. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617713000131
596. Marušič, U., & Grosprêtre, S. (2018). Non‐physical approaches to counteract age‐related functional deterioration: Applications for rehabilitation and neural mechanisms. European Journal of Sport Science. https://doi.org/10.1080/17461391.2018.1447018
597. Mashour, G. A., & Avidan, M. S. (2014). Postoperative Delirium. Anesthesiology. https://doi.org/10.1097/aln.0000000000000330
598. Mastrianni, J. A., & Seibert, K. (2022). Challenging Cases of Neurocognitive Disorders. Seminars in Neurology. https://doi.org/10.1055/s-0042-1760378
599. Mateer, C. A., Sohlberg, M. M., & Youngman, P. K. (2018). The Management of Acquired Attention and Memory Deficits. Routledge eBooks. https://doi.org/10.4324/9780429490088-6
600. Mather, N., & Urso, A. (2010). Learning Disabilities. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0502
601. Matrick, A., Babb, E., & Dinwiddie, S. H. (2021). Assessment of Need for Guardianship: What Is the Role of the Psychiatrist?. Psychiatric Annals. https://doi.org/10.3928/00485713-20210211-01
602. Matta, S. M. D., Moreira, J. M., Kümmer, A., Barbosa, I. G., Teixeira, A. L., & Silva, A. C. S. E. (2014). Cognitive alterations in chronic kidney disease: an update. Brazilian Journal of Nephrology. https://doi.org/10.5935/0101-2800.20140035
603. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
604. Mayer, G., Happe, S., Evers, S., Hermann, W., Jansen, S., Kallweit, U., Muntean, M., Pöhlau, D., Riemann, D., Saletu, M., Schichl, M., Schmitt, W., Sixel-Döring, F., & Young, P. (2021). Insomnia in neurological diseases. Neurological Research and Practice. https://doi.org/10.1186/s42466-021-00106-3
605. Mc, E. (1999). [Epilepsy and learning: a neuropsychological approach].. PubMed.
606. Mc, E. (1999). [Neuropsychological subtypes of the inattention and hyperactivity syndrome].. PubMed.
607. McEvoy, J. P., Asuzu, K., Bradford, D. W., Freudenreich, O., & Moyer, K. (2020). Treatment and management of patients with schizophrenia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0065
608. McIntyre, R. S., & Calabrese, J. R. (2019). Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2019.1636017
609. McIntyre, R. S., Danielle, S., & Soczynska, J. K. (2014). Differentiating cognitive dysfunction from other dimensions of psychopathology in major depressive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199688807.003.0005
610. McIntyre, R. S., Danielle, S., & Soczynska, J. K. (2014). The mediational role of cognition on functional outcomes in major depressive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199688807.003.0006
611. McKinlay, W. W., & Gray, J. (2018). Assessment of the Severely Head-Injured. Routledge eBooks. https://doi.org/10.4324/9780429490316-17
612. McNicholas, N., O’Connell, K., Yap, S. M., Killeen, R. P., Hutchinson, M., & McGuigan, C. (2017). Cognitive dysfunction in early multiple sclerosis: a review. QJM. https://doi.org/10.1093/qjmed/hcx070
613. McPherson, S. (2004). Apathy in Alzheimer’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-661-4_44
614. McWhirter, D., Bae, C., & Budur, K. (2007). The assessment, diagnosis, and treatment of excessive sleepiness: practical considerations for the psychiatrist.. PubMed.
615. Medalia, A., & Lim, R. (2004). Treatment of Cognitive Dysfunction in Psychiatric Disorders. Journal of Psychiatric Practice. https://doi.org/10.1097/00131746-200401000-00003
616. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
617. Medjkane, F., Bohet, M., Ister, M., Cohen, D., Parenti, A., Janati, M., Mention, K., Dobbelaere, D., & Jardri, R. (2021). Onset of psychiatric signs and impaired neurocognitive domains in inherited metabolic disorders: A case series. JIMD Reports. https://doi.org/10.1002/jmd2.12133
618. Medrano‐Martínez, P., Platón, M., & Peraita‐Adrados, R. (2018). Alteraciones neuropsicológicas en la narcolepsia con cataplejía: una revisión. Revista de Neurología. https://doi.org/10.33588/rn.6603.2017448
619. Meehl, P. E. (1989). Schizotaxia Revisited. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1989.01810100077015
620. Meier, L., Weinrebe, W., Annoni, J., & Petersen, J. A. (2022). Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s380316
621. Melo-Dias, C., Apóstolo, J., & Cardoso, D. (2014). Effectiveness of progressive muscle relaxation training for adults diagnosed with schizophrenia: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2014-1639
622. Mendez, M. F. (2006). The Accurate Diagnosis of Early-Onset Dementia. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/q6j4-r143-p630-kw41
623. Menecier, P., Rouaud, O., Arezes, C., Nasr, D., Menecier-Ossia, L., Charvet-Blanc, A., & Ploton, L. (2007). [Bipolar disorders and dementia: fortuitous association or filiation? A case-report and review of the literature]. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2007.0035
624. Meo, E. D., Portaccio, E., Bonacchi, R., Giovannoli, J., Niccolai, C., & Amato, M. P. (2025). An update on the treatment and management of cognitive dysfunction in patients with multiple sclerosis. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2025.2450788
625. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
626. Mesulam, M. (2013). Primary progressive aphasia: A dementia of the language network. Dementia & Neuropsychologia. https://doi.org/10.1590/s1980-57642013dn70100002
627. Meyer, N. J., & Hall, J. B. (2006). Brain dysfunction in critically ill patients--the intensive care unit and beyond.. Critical Care. https://doi.org/10.1186/cc4980
628. Meyers, C. A. (2000). Neurocognitive dysfunction in cancer patients.. PubMed.
629. Mihaljević-Peleš, A., Janović, M. B., Šagud, M., Živković, M., Janović, Š., & Jevtović, S. (2019). Cognitive deficit in schizophrenia: an overview.. PubMed.
630. Mike, A., Charles, G., & Zsolt, I. (2012). Impact of Gray Matter Pathology on Cognitive Function in Multiple Sclerosis. InTech eBooks. https://doi.org/10.5772/25166
631. Millar, H., Saravane, D., Hanssens, L., & Moutard-Martin, F. (2007). Are European psychiatrists concerned about the physical health of their patients suffering from schizophrenia?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2007.01.446
632. Miller, M. A. (2015). The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive Disorders. Frontiers in Neurology. https://doi.org/10.3389/fneur.2015.00224
633. Milovanović, S., Ćulafić, Đ. M., Leposavić, L., & Vojinovic, V. C. (2004). Hepatic encephalopathy in consultative psychiatry: Experience with chlomethiazole. Engrami.
634. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
635. Mkize, D. L. (2003). Evidence-based interventions for dementia in general practice : main topic. CME: Your SA Journal of CPD.
636. MM, B., Islam, S., Nh, S., Rahman, M., & Bari, M. (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
637. Moghaddam, N., Dawson, D. L., Evangelou, N., Turton, J., Hawton, A., Law, G., Roche, B., Rowan, E., Burge, R., Frost, A. C., & Nair, R. D. (2021). Strengthening Mental Abilities with Relational Training (SMART) in Multiple Sclerosis (MS): Study Protocol for a Feasibility Randomised Controlled Trial. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-1145797/v1
638. Molko, N., Wilson, A. J. C., & Dehaene, S. (2005). La dyscalculie développementale, un trouble primaire de la perception des nombres. Revue française de pédagogie. https://doi.org/10.3406/rfp.2005.3362
639. Mollenhauer, B., & Weintraub, D. (2017). The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700737114
640. Molteni, F. (2012). Trattamento della spasticitŕ e della distonia. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003013
641. Monahan, R. C., Middelkoop, H., Voorde, L. B. V. D., Fronczek, R., Kloppenburg, M., Huizinga, T., & Steup-Beekman, M. (2022). S14.3 Cognitive dysfunction is common but associates weakly with quality of life in patients with lupus and neuropsychiatric symptoms. https://doi.org/10.1136/lupus-2022-elm2022.32
642. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
643. Morand, A., Gauthier, K., Mazerolle, M., Pèlerin, A., Rigalleau, F., Sayette, V. D. L., Eustache, F., Desgranges, B., Huguet, P., & Régner, I. (2020). L’effet de menace du stéréotype en situation d’évaluation neuropsychologique : enjeux cliniques. HAL (Le Centre pour la Communication Scientifique Directe). https://doi.org/10.1684/nrp.2020.0607
644. Morimoto, S. S., Kanellopoulos, D., & Alexopoulos, G. S. (2014). Cognitive Impairment in Depressed Older Adults: Implications for Prognosis and Treatment. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-05
645. Moritz, S., Silverstein, S. M., Beblo, T., Zonp, Z., Zink, M., & Gallinat, J. (2021). Much of the Neurocognitive Impairment in Schizophrenia is Due to Factors Other Than Schizophrenia Itself: Implications for Research and Treatment. Schizophrenia Bulletin Open. https://doi.org/10.1093/schizbullopen/sgaa034
646. Morris, J. G., & McManus, D. Q. (1991). The neurology of aging: normal versus pathologic change.. PubMed.
647. Moser, G. (2007). [Psychotherapy in somatic diseases--for example gastrointestinal disorders].. Psychiatria Danubina.
648. Moser, H. W. (1989). Mental Retardation. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6768-8_32
649. Moshé, S. L., Tuchman, R. F., & Rapin, I. (2005). [Neurodevelopmental disorders and epilepsy].. PubMed.
650. Mottron, L., & Burack, J. A. (2012). Sensory, Motor and Attention Characteristics of Autistic Children.
651. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
652. Mula, M., & Trimble, M. (2006). Neuropharmacological Aspects of Cognitive Neurorehabilitation in Epilepsy. Behavioural Neurology. https://doi.org/10.1155/2006/893053
653. Murai, T., Ubukata, S., & Ueda, K. (2019). Interventions for Social / Behavioral Problems after Brain Injury : Essentials and Topics. Higher Brain Function Research. https://doi.org/10.2496/hbfr.39.5
654. Must, A., Horváth, S., & Janka, Z. (2008). [Affective and cognitive decision making in major depression: influence of the prefrontal cortex, serotonin transporter genotype and personality traits]..
655. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
656. Møller, J. T. (1998). Postoperative cognitive decline: the extent of the problem. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-199811000-00027
657. Münster, T., & Tzabazis, A. (2013). Somatische Intervention und Demenz - Einfluss von Chirurgie und Anästhesie auf kognitive Funktionen. PSYCH up2date. https://doi.org/10.1055/s-0033-1343131
658. Müri, R. M., Wagner, J., Nef, T., & Mosimann, U. P. (2011). Cognition and driving in older persons. Schweizerische medizinische Wochenschrift. https://doi.org/10.4414/smw.2011.13136
659. Nabila, B. I., Kurniawan, W. E., & Maryoto, M. (2022). Gambaran Tingkat Demensia pada Lansia di Rojinhome Ikedaen Okinawa Jepang. Cerdika Jurnal Ilmiah Indonesia. https://doi.org/10.59141/cerdika.v2i8.425
660. Naidech, A. M., & Maas, M. B. (2016). Critical Care Neurology Perspective on Delirium. Seminars in Neurology. https://doi.org/10.1055/s-0036-1592318
661. Nasrallah, H. A. (2012). Impaired Mental Proprioception in Schizophrenia. Current psychiatry.
662. Natividad, J. (2020). Improving Cognitive Function in Persons with Dementia Through Music Therapy. https://doi.org/10.33015/dominican.edu/2021.nurs.st.01
663. Navarro, J. C., & Kofke, W. A. (2021). Perioperative Management of Acute Central Nervous System Injury. Perioperative Medicine. https://doi.org/10.1016/b978-0-323-56724-4.00024-1
664. Navrátil, O., Smrčka, M., & Hanak, P. H. (2006). The outcome, working ability and psychic changes after traumatic brain injury.. PubMed.
665. Nebes, R. D., Buysse, D. J., Halligan, E. M., Houck, P. R., & Monk, T. H. (2009). Self-Reported Sleep Quality Predicts Poor Cognitive Performance in Healthy Older Adults. The Journals of Gerontology Series B. https://doi.org/10.1093/geronb/gbn037
666. Nestor, P. J. (2010). 007 Mild cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.217554.7
667. Nicholson, T. R., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., Mildon, B., Nielsen, G., Nicholson, C., Perez, D. L., Pick, S., Stone, J., Anderson, D. G., Asadi‐Pooya, A. A., Aybek, S., Baslet, G., Bloem, B., Brown, R. J., Chalder, T., Damianova, M., ... Tinazzi, M. (2019). Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.19060128
668. Niino, M. (2014). Cognitive impairment in multiple sclerosis. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.54.1058
669. Noeker, M. (2004). [Factitious disorder and factitious disorder by proxy].. PubMed.
670. Nofzinger, E. A., & Reynolds, C. F. (1997). 54 and Sleep Disorders.
671. North, C. S., & Yutzy, S. H. (2018). Delirium and Dementia (Neurocognitive Disorders). Oxford University Press eBooks. https://doi.org/10.1093/med/9780190215460.003.0013
672. Nosek, M. A., & Howland, C. A. (1998). Abuse and Women with Disabilities.
673. Noterdaeme, M., & Springer, S. (2006). Neuropsychological assessment of language and cognition in children with autistic disorders. Neuropediatrics. https://doi.org/10.1055/s-2006-974023
674. Nower, L., & Blaszczynski, A. (2008). Recovery in Pathological Gambling: An Imprecise Concept. Substance Use & Misuse. https://doi.org/10.1080/10826080802285810
675. Oh, J., Stokes, K. A., Tyndel, F., & Freedman, M. (2010). Progressive Cognitive Decline in a Patient With Isolated Chronic Neurosarcoidosis. The Neurologist. https://doi.org/10.1097/nrl.0b013e31819f959b
676. Oken, B. (2003). Non-prescription and non-pharmacological therapies for dementia. CRC Press eBooks. https://doi.org/10.3109/9780203494578-29
677. Oliveira, G. D. C., Escobar, V. S., Alqam, R., Conceição, F. L., Portuguez, M. W., & Leal‐Conceição, E. (2021). Cognitive and emotional aspects of patients with multiple sclerosis during illness and hospitalization process: Contributions of cognitive-behavioral therapy / Aspectos cognitivos e emocionais dos pacientes com esclerose múltipla durante a doença e o processo de hospitalização: Contribuições da terapia cognitivo-comportamental. Brazilian Journal of Development. https://doi.org/10.34117/bjdv7n12-392
678. Oller, J. W. (2013). Assessing Test Takers With Communication Disorders. https://doi.org/10.1002/9781118411360.wbcla086
679. Olney, A. H., Kolodziej, P., Schaefer, G. B., & Buehler, B. A. (1997). Oral-Facial-Digital Syndrome Type I. Ear Nose & Throat Journal. https://doi.org/10.1177/014556139707601104
680. Olson, D. M., Westermarck, T., & Ekvall, S. W. (2005). Seizures And Epilepsy. https://doi.org/10.1093/oso/9780195165647.003.0010
681. Oreja‐Guevara, C., Blanco, T. A., Brieva, L., Pérez, M. Á. H., Meca‐Lallana, V., & Ramió‐Torrentà, L. (2019). Cognitive Dysfunctions and Assessments in Multiple Sclerosis. Frontiers in Neurology. https://doi.org/10.3389/fneur.2019.00581
682. Orme, S., & Harari, D. (2020). Bladder and bowels. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0060
683. Ospina, B., & Vélez, J. L. O. (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
684. Ouerfelli‐Ethier, J., Elsaeid, B., Groseilliers, J. D., Ouchene, L., Munoz, D. P., Blohm, G., & Khan, A. Z. (2018). AB073. Correlations between control of saccadic eye movements and performance in other cognitive tasks in younger adults, older adults and patients with Parkinson’s disease. Annals of Eye Science. https://doi.org/10.21037/aes.2018.ab073
685. Outhoff, K. (2016). Cognitive enhancement : a brief overview : review. South African Family Practice.
686. Outhoff, K. (2016). Cognitive enhancement: a brief overview. South African Family Practice. https://doi.org/10.4102/safp.v58i1.4436
687. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
688. Pachana, N. A., Hosseini, C., & Pinsker, D. (2022). Psychiatric Disorders in Older Adults. Routledge eBooks. https://doi.org/10.4324/9781003100058-11
689. Palermo, M. T., & Greydanus, D. E. (2011). Social Cognition, Executive Dysfunction and Neuro-Behavioral Karate: Alternative Medicine or Psychomotor Treatment?. International journal of child and adolescent health.
690. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
691. Palmer, S. C., Zwieten, A. V., Saglimbene, V., Ruospo, M., & Strippoli, G. F. (2022). Neurocognitive Disorders. https://doi.org/10.1002/9781119105954.ch75
692. Palmirotta, C., Turi, G., Tagliente, S., Pansini, M., Trane, S. D., & Lagravinese, G. (2024). The Effects of Intensive Rehabilitation Combined with Thiamine Treatment on Cognitive Recovery in a Case of Non-Alcoholic Wernicke–Korsakoff Syndrome. Neurology International. https://doi.org/10.3390/neurolint16010018
693. Pan, Z., Grovu, R. C., Danielle, S., Carmona, N. E., Subramaniapillai, M., Shekotikhina, M., Rong, C., Lee, Y., & McIntyre, R. S. (2018). Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527316666170919115100
694. Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2018). Cognitive impairment in major depressive disorder. CNS Spectrums. https://doi.org/10.1017/s1092852918001207
695. Panfilova, E., Bobylova, M. Y., Kapustina, A. A., Braudo, T. A., Abramov, M. O., & Klepikov, N. I. (2017). Motor and sensory alalia: diagnostic difficulties. Russian Journal of Child Neurology. https://doi.org/10.17650/2073-8803-2017-12-4-32-42
696. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
697. Park, J. H., Kim, H.-C., Lee, J. H., Kim, J. S., Roh, S. Y., Yi, C. H., Kang, Y. K., & Kwon, B. S. (2009). Development of Korean Academy of Medical Sciences Guideline for Rating Physical Disability of Upper Extremity. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2009.24.s2.s288
698. Parker, K. P., Bliwise, D. L., & Rye, D. B. (1999). Excessive Daytime Sleepiness and Functioning in Dialysis Patients. Seminars in Dialysis. https://doi.org/10.1046/j.1525-139x.1999.99014.x
699. Parker, R. S. (2012). Chronic Posttraumatic Disorders of Consciousness. CRC Press eBooks. https://doi.org/10.1201/b10562-14
700. Parrott, A. C. (2000). Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change. Neuropsychobiology. https://doi.org/10.1159/000026666
701. Parsons, M. W., & Dietrich, J. (2021). Assessment and Management of Cognitive Symptoms in Patients With Brain Tumors. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_320813
702. Parčina, M. (2017). ORGANIZACIJA RADA USTANOVE ZA ZAPOŠLJAVANJE, RAD I PROFESIONALNU REHABILITACIJU OSOBA S INVALIDITETOM.
703. Patchner, L. S., & DeWeaver, K. L. (2013). Disability: Neurocognitive Disabilities. Encyclopedia of Social Work. https://doi.org/10.1093/acrefore/9780199975839.013.542
704. Patel, D. R., & Merrick, J. (2020). Neurodevelopmental and neurobehavioral disorders. Translational Pediatrics. https://doi.org/10.21037/tp.2020.02.03
705. Patricia, G. C. C., AAngela, G.-M., & Marina, R.-A. (2017). Diagnostic and therapeutical challenges of late-onset psychosis.. Journal of Psychology and Cognition. https://doi.org/10.35841/psychology-cognition.2.4.218-220
706. Patti, F. (2012). Treatment of cognitive impairment in patients with multiple sclerosis. Expert Opinion on Investigational Drugs. https://doi.org/10.1517/13543784.2012.716036
707. Paul, R., Graber, J. R., Bowlby, D. C., Testa, J. A., Harnish, M. J., & Beatty, W. W. (1998). Remote memory in neurodegenerative disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544378.011
708. Paulig, M. (2006). Kognitive Störungen bei idiopathischem Parkinson-Syndrom. psychoneuro. https://doi.org/10.1055/s-2006-955079
709. Payne, T. R., & Wong, G. (2022). Hearing loss: Conductive versus sensorineural. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/17557380211070030
710. Pearson, O., Busse, M., Deursen, R. W. M. V., & Wiles, C. M. (2004). Quantification of walking mobility in neurological disorders. QJM. https://doi.org/10.1093/qjmed/hch084
711. Peavy, G. M., Jacobson, M. W., Goldstein, J., Hamilton, J. M., Kane, A., Gamst, A., Lessig, S., Lee, J. C., & Corey‐Bloom, J. (2010). Cognitive and functional decline in Huntington's disease: Dementia criteria revisited. Movement Disorders. https://doi.org/10.1002/mds.22953
712. Peitl, V., Paleka, F., & Karlović, D. (2025). Catatonia and cognition: exploring the cognitive dimensions of catatonia as an overlooked aspect of schizophrenia. A systematic review.. PubMed. https://doi.org/10.1708/4548.45488
713. Pejović-Nikolić, S. (2011). [Neurobiological disturbances in insomnia: clinical utility of objective sleep measures].. PubMed.
714. Pelc, K., Chéron, G., & Dan, B. (2011). The Lessons from Angelman Syndrome for Research and Management. InTech eBooks. https://doi.org/10.5772/21808
715. Pennington, B. F., & Peterson, R. L. (2015). Neurodevelopmental Disorders: Learning Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch46
716. Pennisi, M., Bramanti, A., Cantone, M., Pennisi, G., Bella, R., & Lanza, G. (2017). Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2017.00498
717. Peper, E., & Harvey, R. (2018). Digital Addiction: Increased Loneliness, Anxiety, and Depression. NeuroRegulation. https://doi.org/10.15540/nr.5.1.3
718. Perat, M. V. (2006). NEW ADVANCES IN TREATMENT OF CEREBRAL PALSY. Neuropediatrics. https://doi.org/10.1055/s-2006-945551
719. Perera-W.A., H., Salehuddin, K., Khairudin, R., & Schaefer, A. (2021). Eeg sebagai Kaedah Berkesan untuk Memahami Aktiviti Neural Berkaitan Keupayan Golongan Miskin Membuat Keputusan (Eeg as an Effective Method to Measure Neural Correlates of Decision-Making in Poverty). Akademika.
720. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
721. Perrar, K. M. (2012). Palliative Therapie bei Hochbetagten und Demenzkranken. Arzneimittelforschung. https://doi.org/10.1055/s-0031-1300569
722. Petersen, R. C. (2004). Mild cognitive impairment (MCI), amnestic type. https://doi.org/10.1093/oso/9780195177442.003.0050
723. Petruševičienė, D., & Kriščiūnas, A. (2003). [Occupational therapy for patients after stroke].. PubMed.
724. Peven, J. C., Stillman, C. M., & Erickson, K. I. (2019). The Influence of Physical Exercise on Cognitive Aging. Cambridge University Press eBooks. https://doi.org/10.1017/9781108554350.016
725. Piendl, T. A. (2015). Auswirkungen von depressiven Störungen auf die kognitive Leistungsfähigkeit und die Fahrkompetenz.
726. Pillon, A., & Samson, D. (2003). Les troubles sémantiques catégoriels reflètent l'organisation catégorielle de la mémoire sémantique. Revue de neuropsychologie.
727. Pincham, H. (2014). The Neural Correlates of Working Memory Impairment in Attention-Deficit/Hyperactivity Disorder. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0487-14.2014
728. Pincherle, A., Rossi, F., Jöhr, J., Dunet, V., Ryvlin, P., Oddo, M., Schiff, N., & Diserens, K. (2020). Early discrimination of cognitive motor dissociation from disorders of consciousness: pitfalls and clues. Journal of Neurology. https://doi.org/10.1007/s00415-020-10125-w
729. Pj, O. (1998). [Cognitive manifestations of Alzheimer's disease].. PubMed.
730. Poewe, W., & Luginger, E. (1999). Depression in Parkinson's disease: impediments to recognition and treatment options.. PubMed.
731. Poljak, T. H. (2018). "Alzheimer’s dementia ". Hospice and Palliative Medicine International Journal. https://doi.org/10.15406/hpmij.2018.02.00084
732. Polukchi, T. V., Zharkinbekova, N., Erkebayeva, S., Tuksanbayeva, G., Mustapayeva, G., & Yessetova, A. (2024). Modern Approaches to Diagnosing Cognitive Impairments in Patients with Multiple Sclerosis. Journal of Clinical Medicine of Kazakhstan. https://doi.org/10.23950/jcmk/15182
733. Portes, V. D., & Héron, D. (2020). Trastornos del desarrollo intelectual. Contraste.
734. Postma, A., Nelson, C. M., Dijk, J. V., & Dijk, R. V. (2010). Deaf Children with Severe Multiple Disabilities:. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195390032.013.0012
735. Potvin, S., Stavro, K., & Pelletier, J. (2012). Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors. Journal of Dual Diagnosis. https://doi.org/10.1080/15504263.2012.648549
736. Powers, S. W., Gilman, D. K., & Hershey, A. D. (2006). Headache and Psychological Functioning in Children and Adolescents. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2006.00583.x
737. Powlishta, K. K., Storandt, M., Mandernach, T., Hogan, E., Grant, E., & Morris, J. C. (2004). Absence of Effect of Depression on Cognitive Performance in Early-Stage Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneur.61.8.1265
738. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
739. Pradhea, T. A., Dwikarlina, I., Putra, A. W., Agustina, L., & Nardian, D. F. (2024). Gangguan Kognitif Pasca-Stroke – Tinjauan Sistematik. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v51i12.1239
740. Prenger, M. T. M., Madray, R., Hedger, K. V., Anello, M., & MacDonald, P. A. (2020). Social Symptoms of Parkinson’s Disease. https://doi.org/10.20944/preprints202007.0604.v1
741. Prenger, M., Madray, R., Hedger, K. V., Anello, M., & MacDonald, P. A. (2020). Social Symptoms of Parkinson’s Disease. Parkinson s Disease. https://doi.org/10.1155/2020/8846544
742. Previgliano, I., Andres, B., & Ciesielczyk, P. J. (2015). Long-term Cognitive Impairment after Critical Illness – Definition, Incidence, Pathophysiology and Hypothesis of Neurotrophic Treatment. European Neurological Review. https://doi.org/10.17925/enr.2015.10.02.195
743. Prigatano, G. P., Hendin, B., & Heiserman, J. E. (2014). Denial or unawareness of cognitive deficit associated with multiple sclerosis? A case report. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2014.890700
744. Prvčić, I., Zec, M. R., & Barišić, I. (2008). Psychological aspects of learning disabilities. Paediatria Croatica. https://doi.org/10.13112/pc.925
745. PRYVALOVA, N., NEGREBA, T., Sukhorukov, V., & Bovt, Y. (2021). [NEUROPSYCHOLOGICAL ANALYSIS OF DISORDERS OF HIGHER MENTAL FUNCTIONS IN PATIENTS WITH DIFFERENT TYPES OF MULTIPLE SCLEROSIS].. PubMed.
746. Pujalte, G. G., & Benjamin, H. J. (2018). Sleep and the Athlete. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0000000000000468
747. Putri, P. R. N. E. (2020). Asuhan keperawatan diabetes mellitus tipe 2 dengan ulkus diabetik pada ny. J di upt puskesmas rawat inap sungai pakning.
748. Pérez, J. A. P., Mateos, R. M., García-Tenorio, M. J. G., Pavón, A. T., Leal, J. R. R., Aguirre, V. E. P., Arias, R. M., & Morán, R. M. B. (1997). Prevención primaria del fracaso escolar: El cuestionario de madurez neuropsicológica infantil (CUMANIN). Un estudio experimental. Educational Psychology.
749. Pérez, P. S. (2015). El déficit cognitivo en el síndrome de fatiga crónica: factores asociados y evolución.
750. Qiu, N., Li, P., Li, Y., Li, K., Yan, H., Gan, X., Li, Y., Hu, L., Becker, B., & Yao, D. (2025). Impaired experience-based attentional suppression in major depression: a neurophysiological and cognitive vulnerability marker. medRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2025.07.28.25332298
751. Qualls, S. H. (2002). Defining Mental Health in Later Life. Generations.
752. Queiroz, A. P. D. S., Pedro, M. O. P., Campos, M. W., Torales, J., Ventriglio, A., & Castaldelli-Maia, J. M. (2025). Cognitive Effects of Cannabis Use: A Comprehensive Review Across Domains. Neurology International. https://doi.org/10.3390/neurolint17070107
753. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve Mild cognitive impairment.
754. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v94i3p162-168
755. Raga, S., Specchio, N., Rheims, S., & Wilmshurst, J. M. (2021). Developmental and epileptic encephalopathies: recognition and approaches to care. Epileptic Disorders. https://doi.org/10.1684/epd.2021.1244
756. Ramanan, S., & Kumar, D. (2013). Prospective Memory in Parkinson's Disease: A Meta-analysis. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617713001045
757. Ramey, T., & Regier, P. S. (2018). Cognitive impairment in substance use disorders. CNS Spectrums. https://doi.org/10.1017/s1092852918001426
758. Ramig, L. O., & Verdolini, K. (1998). Treatment Efficacy. Journal of Speech Language and Hearing Research. https://doi.org/10.1044/jslhr.4101.s101
759. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
760. Rao, N., & Suhas, S. (2019). Neurocognitive deficits in obsessive–compulsive disorder: A selective review. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_517_18
761. Rao, S. M. (2004). Cognitive Function in Patients with Multiple Sclerosis: Impairment and Treatment. International Journal of MS Care. https://doi.org/10.7224/1537-2073-6.1.9
762. Rao, S. M., & Doraiswamy, P. M. (2004). Treating cognitive deficits in multiple sclerosis. Neurology. https://doi.org/10.1212/01.wnl.0000146628.30692.15
763. Rasmussen, J., Blashill, A. J., Greenberg, J. L., & Wilhelm, S. (2013). Body Dysmorphic Disorder. https://doi.org/10.1002/9781118528563.wbcbt47
764. Ravdin, L., Mattis, P. J., & Lachs, M. S. (2004). Assessment of cognition in primary care: neuropsychological evaluation of the geriatric patient.. PubMed.
765. Reid, W. H., Balis, G. U., & Sutton, B. (1997). The treatment of psychiatric disorders : revised for DSM-IV.
766. Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019). Long-term Cognitive and Functional Impairments After Critical Illness. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004066
767. Rest, M. V., Nieuwenhuijzen, M. V., Kupersmidt, J. B., Vriens, A., Schuengel, C., & Matthys, W. (2018). Accidental and Ambiguous Situations Reveal Specific Social Information Processing Deficits in Vulnerable Adolescents.
768. Reynolds, C. F., Alexopoulos, G. S., & Katz, I. R. (2002). Geriatric Depression: Diagnosis and Treatment. Generations.
769. Riaz, Y., & Sergi, C. (2021). Feeding Disability In Children.
770. Richardson, K. (2017). Cortical Inhibition and Working Memory in Schizophrenia: A TMS-EEG Study. https://doi.org/10.4225/03/58dafea669e1c
771. Riemann, D., Benz, F., Dressle, R. J., Espie, C. A., Johann, A. F., Blanken, T. F., Leerssen, J., Wassing, R., Henry, A. L., Kyle, S. D., Spiegelhalder, K., & Someren, E. J. V. (2022). Insomnia disorder: State of the science and challenges for the future. Journal of Sleep Research. https://doi.org/10.1111/jsr.13604
772. Rigaud, J., Lheureux, P., & Sauder, P. (2006). Prise en charge symptomatique : neurologique, respiratoire, hémodynamique et hépatique des intoxications graves par médicaments et substances illicites. Réanimation. https://doi.org/10.1016/j.reaurg.2006.08.002
773. Riordan, S. M., & Williams, R. R. (2010). Gut Flora and Hepatic Encephalopathy in Patients with Cirrhosis. New England Journal of Medicine. https://doi.org/10.1056/nejme1000850
774. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
775. Rnic, K., & Dozois, D. J. A. (2020). Depression. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch197
776. Roby-Brami, A., Jarrassé, N., & Parry, R. (2021). Impairment and Compensation in Dexterous Upper-Limb Function After Stroke. From the Direct Consequences of Pyramidal Tract Lesions to Behavioral Involvement of Both Upper-Limbs in Daily Activities. Frontiers in Human Neuroscience. https://doi.org/10.3389/fnhum.2021.662006
777. Rockwood, K. (2012). Is the development of late-life cognitive impairment more dynamic than sexy?. Neurology. https://doi.org/10.1212/wnl.0b013e3182455724
778. Rodríguez, A. V. A. (2021). Síndrome dis-ejecutivo: perfil neuropsicológico e intervención neuropsicológica..
779. Rohaut, B., Raimondo, F., Galanaud, D., Valente, M., Sitt, J., & Naccache, L. (2017). Probing consciousness in a sensory-disconnected paralyzed patient. Figshare. https://doi.org/10.6084/m9.figshare.5151409
780. Rohaut, B., Raimondo, F., Galanaud, D., Valente, M., Sitt, J., & Naccache, L. (2017). Probing consciousness in a sensory-disconnected paralyzed patient. Figshare. https://doi.org/10.6084/m9.figshare.5151409.v1
781. Rollin‐Sillaire, A., Delbeuck, X., Pollet, M., Mackowiak, M., Lenfant, P., Noël, M., Façon, T., Leleu, X., Pasquier, F., & Rhun, É. L. (2013). Memory loss during lenalidomide treatment: a report on two cases. BMC Pharmacology and Toxicology. https://doi.org/10.1186/2050-6511-14-41
782. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
783. Rothenberger, A., & Hüther, G. (1997). [The role of psychosocial stress in childhood for structural and functional brain development:neurobiological basis of developmental psychopathology].. PubMed.
784. Rowe, J. B. (2010). Conversion disorder: understanding the pathogenic links between emotion and motor systems in the brain. Brain. https://doi.org/10.1093/brain/awq096
785. Rozzini, L., Chilovi, B. V., Conti, M. Z., Delrio, I., Borroni, B., Trabucchi, M., & Padovani, A. (2007). Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000111133
786. Rubio, S. V. (2019). Funcionamiento neurocognitivo y psicosocial de pacientes con trastorno bipolar en una unidad de salud mental.
787. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
788. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
789. Ruiz‐Rizzo, A. L., & Restrepo, F. L. (2008). Memoria explícita en el trastorno depresivo mayor. IATREIA. https://doi.org/10.17533/udea.iatreia.4479
790. Ruoff, C., & Rye, D. B. (2016). The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2016.1208643
791. Rupani, K., & Adarkar, S. (2022). Optimizing Patient Care in Sleep Disorders. Routledge eBooks. https://doi.org/10.4324/9780429030260-28
792. Rye, D. B., Daley, J. T., Freeman, A., & Bliwise, D. L. (2003). Daytime Sleepiness and Sleep Attacks in Idiopathic Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-326-2_39
793. Rémi, J., Pollmächer, T., Spiegelhalder, K., Trenkwalder, C., & Young, P. (2019). Sleep-Related Disorders in Neurology and Psychiatry. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2019.0681
794. Sa, H. (2013). Diabetes Mellitus And The Brain: Special Emphasis To Cognitive Function. International Journal of Diabetology & Vascular Disease Research. https://doi.org/10.19070/2328-353x-130007
795. Sadat‐Ebrahimi, S., Farhang, S., iei, A. S., jani, Ghaemmaghami, M., & Hoseintorabi, B. (2019). A randomized clinical trial of the therapeutic effect of Transcranial direct current stimulation on working Memory in recent-onset Schizophrenia.
796. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
797. Saint‐Jean, O., Antoine, Edy, Souid, M., & Barthélémy, F. (2004). [Concerning: aging, the beginning of dialysis, the beginning of dependence: repercussions on the psychopathology of the very old dialysis patient].. PubMed.
798. Sakakibara, R., Uchiyama, T., Kanda, T., Uchida, Y., Kishi, M., & Hattori, T. (2008). [Urinary dysfunction in idiopathic normal pressure hydrocephalus].. Brain and nerve.
799. Saletu‐Zyhlarz, G., Anderer, P., & Saletu, B. (2013). [Sleep disorders in psychiatry and their treatment].. PubMed.
800. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
801. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
802. Sasbón, J. S., & Arroyo, H. (2014). Toxic Metabolic Encephalopathy. Pediatric Critical Care Medicine. https://doi.org/10.1007/978-1-4471-6356-5_39
803. Sass, L. A. (2022). Subjectivity, psychosis and the science of psychiatry. World Psychiatry. https://doi.org/10.1002/wps.20986
804. Savage, G. (2010). Neuropsychological assessment of dementia. CRC Press eBooks. https://doi.org/10.1201/b13196-20
805. Sayarifard, A., & Ghadirian, L. (2013). Mental health literacy in iran: an urgent need for a remedy.. PubMed.
806. Sc, D., Mj, W., Hh, K.-L., Houten, V., & Eurelings, M. (2014). [Concentration problem or epilepsy? Sudden changes in behaviour in adolescents].. PubMed.
807. Scheid, T. L., & Wright, E. R. (2017). Theoretical Perspectives on Mental Health and Illness: Introduction to Part I. Cambridge University Press eBooks. https://doi.org/10.1017/9781316471289.003
808. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
809. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
810. Schildkrout, B. (2014). Dementia. https://doi.org/10.1002/9781394260447.ch12
811. Schmidt, M. H., Dekkers, M., Baillieul, S., Jendoubi, J., Wulf, M.-A., Wenz, E., Fregolente, L., Vorster, A., Gnarra, O., & Bassetti, C. L. (2021). Measuring Sleep, Wakefulness, and Circadian Functions in Neurologic Disorders. Sleep Medicine Clinics. https://doi.org/10.1016/j.jsmc.2021.08.005
812. Schmidt, W. (2005). Dopamine and Glutamate in Motor and Cognitive Symptoms of Parkinson’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-852-6_22
813. Schroeder, R. W., Martin, P. K., & Walling, A. (2019). Neuropsychological Evaluations in Adults.. PubMed.
814. Schweitzer, J. B. (2010). Attention‐Deficit/Hyperactivity Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0096
815. Schwerthöffer, D., Fatke, B., & Förstl, H. (2020). Dilemmasituation: Nächtlicher Unruhezustand beim älteren Patienten.
816. Schölzel-Dorenbos, C. J. (2006). MILD BEHAVIORAL IMPAIRMENT: A PRODROMAL STAGE OF FRONTOTEMPORAL LOBAR DEGENERATION. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2005.00575_11.x
817. Seay, O. J., & Marcos, S. (2006). EVALUATING MENTAL RETARDATION FOR FORENSIC PURPOSES.
818. Seichepine, D. R., Neargarder, S., Miller, I. N., Riedel, T. M., Gilmore, G. C., & Cronin‐Golomb, A. (2011). Relation of Parkinson's Disease Subtypes to Visual Activities of Daily Living. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617711000853
819. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
820. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
821. Sellal, F., Wolff, V., & Marescaux, C. (2004). The cognitive pattern of vascular dementia and its assessment. Seminars in Cerebrovascular Diseases and Stroke. https://doi.org/10.1053/j.scds.2004.10.001
822. Seo, E.-S. (2004). Cognitive Dysfunction in Children. Korean Journal of Pediatrics.
823. Sesarini, C. (2015). GABAergic neurotransmission alterations in autism spectrum disorders. Neurotransmitter. https://doi.org/10.14800/nt.1052
824. Shankar, R., Wilcock, M., Oak, K., McGowan, P., & Sheehan, R. (2018). Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.2018.000009
825. Shany‐Ur, T., & Rankin, K. P. (2011). Personality and social cognition in neurodegenerative disease. Current Opinion in Neurology. https://doi.org/10.1097/wco.0b013e32834cd42a
826. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
827. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
828. Shigematsu, K., Takeuchi, H., & Maruhama, S. (2019). P1-297: COGNITIVE FUNCTION ASSESSMENT TESTS SYSTEM USING A TABLET COMPUTER IS USEFUL TO OBTAIN BIG DATA WITH MINIMAL MAN POWER AND IS APPLICABLE FOR GROUP MEDICAL EXAMINATION AND PROSPECTIVE COHORT STUDY. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2019.06.852
829. Shiguango, J. A. O., Cárdenas, M. G. P., Calvopiña, G. C. A., Maza, X. M. S., Segovia, K. X. V., Reyes, L. A. J., Flores, D. P. Z., Montenegro, G. P. H., & Cedeño, S. D. D. (2020). Tratamiento del delirium en pacientes en cuidados intensivos. Archivos venezolanos de farmacología y terapéutica.
830. Shiguango, J. A. O., Cárdenas, M. G. P., Calvopiña, G. C. A., Maza, X. M. S., Segovia, K. X. V., Reyes, L. A. J., Flores, D. P. Z., Montenegro, G. P. H., & Cedeño, S. D. D. (2020). Tratamiento del delirium en pacientes en cuidados intensivos. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.4064961
831. Shih, T., & Bazil, C. W. (2005). Treatment of Generalized Convulsive Status Epilepticus. Humana Press eBooks. https://doi.org/10.1385/1-59259-945-1:265
832. Shneerson, J. M., & Randall, D. C. (2008). Narcolepsy: effects on cognitive functioning, memory, and psychomotor performance. CRC Press eBooks. https://doi.org/10.3109/9780203091715-57
833. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
834. Silverberg, N. D., & Rush, B. (2023). Neuropsychological evaluation of functional cognitive disorder: A narrative review. The Clinical Neuropsychologist. https://doi.org/10.1080/13854046.2023.2228527
835. Singh, P., Anuradha, S., & Jahan, M. (2014). Efficacy of Cognitive Remediation in EpilepsyEfficacy of Cognitive Remediation in Epilepsy. JOURNAL OF PSYCHOSOCIAL RESEARCH.
836. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
837. Smith, H. S., & Jackson, K. C. (2008). Optimizing pharmacologic outcomes: Drug selection. https://doi.org/10.1093/oso/9780195339499.003.0005
838. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
839. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
840. Smith, T. E., Hull, J. W., ISRAEL, L. M., & Willson, D. F. (2000). Insight, Symptoms, and Neurocognition in Schizophrenia and Schizoaffective Disorder. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a033439
841. Sokolowski, K., Erwin, L., Liu, J., Authier, S., McMaster, O., Pressly, B., Bolon, B., & Delatte, M. S. (2025). Identifying and Understanding Seizure Liability in Drug Development. International Journal of Toxicology. https://doi.org/10.1177/10915818241307851
842. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
843. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
844. Song, Z., & Huang, W. (2014). Researches of cognitive disorders and electroencephalogram in patients with Parkinson's disease. Chinese Journal of Neuromedicine. https://doi.org/10.3760/cma.j.issn.1671-8925.2014.10.024
845. Sonino, N., & Fava, G. A. (2007). Rehabilitation in Endocrine Patients: A Novel Psychosomatic Approach. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000107558
846. Soysal, P., & Işık, A. T. (2014). Hypoactive Delirium Caused by Pulmonary Embolus in an Elderly Adult. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12720
847. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
848. Spiegel, R. (2002). Rivastigmina: una revisión de su eficacia clínica. Revista de Neurología. https://doi.org/10.33588/rn.3509.2002002
849. Spikman, J. M., Westerhof-Evers, H. J., & Cassel, A. (2021). Remediating impairments in social cognition. Routledge eBooks. https://doi.org/10.4324/9781003027034-11
850. Stafstrom, C. E., Moshé, S. L., Swann, J. W., Nehlig, A., Jacobs, M., & Schwartzkroin, P. A. (2006). Models of Pediatric Epilepsies: Strategies and Opportunities. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00674_1.x
851. Stahl, S. M., & Morrissette, D. A. (2018). CME Information. https://doi.org/10.1017/9781107706842.002
852. Stahl, S. M., & Morrissette, D. A. (2018). Treatment of Secondary Behavioral Symptoms of Dementia. https://doi.org/10.1017/9781107706842.008
853. Stanghellini, G. (2016). Abnormal time experience, bizarre delusions and verbal-acoustic hallucinations in schizophrenia. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.860
854. Staniloiu, A., & Markowitsch, H. J. (2013). 1687 – Social cognition in patients with dissociative amnesia. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76675-6
855. Staniloiu, A., & Markowitsch, H. J. (2013). 1699 – Long lasting personality changes after the onset of dissociative amnesia. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76685-9
856. Stark, M. E. (1999). Challenging Problems Presenting As Constipation. The American Journal of Gastroenterology. https://doi.org/10.1111/j.1572-0241.1999.00917.x
857. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
858. Stevens, R. D., Sharshar, T., & Ely, E. W. (2013). Diagnosis of Brain Dysfunction. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139248822.026
859. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
860. Stoohs, R., Guilleminault, C., & Quera-Salva, M. (1992). Sleep-related obstructive and nonobstructive apneas and neurologic disorders.. PubMed.
861. Strassnig, M., & Harvey, P. D. (2013). Treatment of obesity and disability in schizophrenia.. PubMed.
862. Strilchuk, L. M. (2021). Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment. Contemporary cardiology. https://doi.org/10.1007/978-3-030-62632-7_10
863. Stringer, S., Nieman, D. H., Kahn, R. S., & Derks, E. M. (2015). Genome-wide association analysis in schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781107337459.010
864. Strosahl, K. D. (2022). ACT con el paciente multiproblemático. ABA España eBooks. https://doi.org/10.26741/978-84-09-43990-4_09
865. Strupp, M., Kremmyda, O., Adamczyk, C., Böttcher, N., Muth, C., Yip, C. W., & Brémovà-Ertl, T. (2014). Central ocular motor disorders, including gaze palsy and nystagmus. Journal of Neurology. https://doi.org/10.1007/s00415-014-7385-9
866. Stuchlı́k, A., Petrásek, T., Hatalov, H., Rambousek, L., Nekovářová, T., & Valeš, K. (2012). Behavioral Tests for Evaluation of Information Processing and Cognitive Deficits in Rodent Animal Models of Neuropsychiatric Disorders. InTech eBooks. https://doi.org/10.5772/37844
867. Suchyta, M. R., & Hopkins, R. O. (2007). Neurologic Sequelae in Critical Illness: Evaluation and Outcomes. Current Respiratory Medicine Reviews. https://doi.org/10.2174/157339807782359904
868. Suciu, B., Panescu, R., & Micluția, I. (2017). Cognitive impairment in major depressive disorder. Romanian Journal of Psychiatry & Psychotherapy. https://doi.org/10.37897/rjpp.2017.1.3
869. Suciu, B., Paunescu, R., & Micluția, I. (2017). Patterns of Impairment in Executive Functions within Unipolar and Bipolar Depression. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.2182
870. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
871. Sumeyra, H. A. (2021). PSYCHO-PEDAGOGICAL CHARACTERISTICS OF YOUNG STUTTERING STUDENTS. Innovate Pedagogy. https://doi.org/10.32843/2663-6085/2021/40.21
872. Sumiyoshi, T. (2008). Possible dose–side effect relationship of antipsychotic drugs: relevance to cognitive function in schizophrenia. Expert Review of Clinical Pharmacology. https://doi.org/10.1586/17512433.1.6.791
873. Summergrad, P. (2015). Homeless and impaired: the burden of serious psychiatric illness. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12403
874. Sun, M. (2018). Executive functioning: perspectives on neurotrophic activity and pharmacology. Behavioural Pharmacology. https://doi.org/10.1097/fbp.0000000000000427
875. Sunagawa, K., Funayama, M., Nakagawa, Y., Houjou, T., & Tanemura, R. (2016). Visuospatial deficits and operation of electronic devices. Higher Brain Function Research. https://doi.org/10.2496/hbfr.36.402
876. Sunarti, S., & Helena, H. (2018). Gangguan Tidur pada Lanjut Usia. Journal of Islamic Medicine. https://doi.org/10.18860/jim.v2i1.5009
877. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
878. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
879. Sussman, S., & Ames, S. L. (2008). Concepts of Cessation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511500039.016
880. Sutton, F., Bârcă, D., Komoltsev, I., Craiu, D., Guekht, A., Oertzen, T. J. V., & Cock, H. R. (2020). Testing blood and CSF in people with epilepsy: a practical guide. Epileptic Disorders. https://doi.org/10.1684/epd.2020.1191
881. Suzuki, Y. (2012). Mild Cognitive Impairment. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.71.385
882. Suárez, A. L. Á. (2022). Evaluación del efecto antidepresivo del secretoma derivado de células madre mesenquimáticas precondicionadas en un modelo animal de trastorno depresivo mayor. https://doi.org/10.52611/11447/6617
883. Szela̧g, E. (2016). Wspomaganie mocy umysłu - fakty, mity i perspektywy. Wszechświat.
884. Szirmai, I., & Kovács, T. (2002). [Parkinson syndrome and cognitive disorders].. PubMed.
885. Tachibana, N., Kimura, K., Kitajima, K., Shinde, A., Kimura, J., & Shibasaki, H. (1997). REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.63.5.678
886. Takeda, A. (2014). [Neuropsychological tests in multiple sclerosis].. PubMed.
887. Tang, K., Antshel, K. M., Fremont, W., & Kates, W. R. (2015). Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome. Journal of Developmental & Behavioral Pediatrics. https://doi.org/10.1097/dbp.0000000000000210
888. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
889. Taxirovna, D. S., Otabekovich, S. A., & Taxirovna, D. A. (2021). Prevention and Treatment of Cognitive Dysfunctions in Patients with Discirculatory Enfephalopathy. Annals of the Romanian Society for Cell Biology.
890. Taylor, M. E., & Whitney, J. (2021). Impaired Cognition and Falls. Cambridge University Press eBooks. https://doi.org/10.1017/9781108594455.009
891. Teja, N., Gummadi, O. D., Devi, B. V., & Pavani, N. (2020). Evaluation of Depressant Activity on Mansoa alliacea on Rats. Acta Scientific Pharmaceutical Sciences. https://doi.org/10.31080/asps.2020.04.0617
892. Teunis, T., Janssen, S. J., Guitton, T. G., Ring, D., & Parisien, R. (2015). Do Orthopaedic Surgeons Acknowledge Uncertainty?. Clinical Orthopaedics and Related Research. https://doi.org/10.1007/s11999-015-4623-0
893. Tg, A., An, B., & Ei, G. (2000). [Spectrum of neuropsychological changes in multiple sclerosis].. PubMed.
894. Thomas, M., Christopher, G., Williams, N. F., & Heirene, R. (2015). Measuring fatigue and related symptoms in adults with Developmental Coordination Disorder (DCD).
895. Thomas, N., & Pantelis, C. (2015). Psychotic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp535
896. Todd, O., & Teale, E. (2016). Delirium: a guide for the general physician. Clinical Medicine. https://doi.org/10.7861/clinmedicine.16-6-s98
897. Tomasetti, C. (2014). Spatial and temporal patterns of postsynaptic genes and proteins expression by multiple receptors targeting agents: unraveling the impact of multitargeting approach on dopamine-glutamate mediated synaptic plasticity.
898. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
899. Tonković, D., Adam, V. N., Kovačević, M., Bogović, T. Z., Drvar, Z., & Baronica, R. (2012). [Perioperative disorders of mental functions].. PubMed.
900. Torpy, J. M. (2008). Delirium. JAMA. https://doi.org/10.1001/jama.300.24.2936
901. Torpy, J. M. (2008). Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.300.13.1610
902. Torpy, J. M. (2009). Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.302.4.452
903. Torpy, J. M. (2010). Delirium. JAMA. https://doi.org/10.1001/jama.304.7.814
904. Tostes, J. G., Vasconcelos, A. C. B. D., Tostes, C. B. D. S., Brito, K. A. N. D. D., Souza, T. F. D., & Freitas, R. L. D. (2020). Esquizofrenia e Cognição. Revista Psicologia em Pesquisa. https://doi.org/10.34019/1982-1247.2020.v14.30284
905. Toulopoulouand, T., & Murray, R. (2004). Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.4.1.43
906. Trahan, M. A., Kahng, S., Donaldson, J. M., & McNabney, M. (2013). “Just Make it Stop”: A Case Report of Excessive Crying in an Individual with Dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.12339
907. Tranel, D., Grabowski, T. J., & Damásio, H. (2003). Behavioral Neurology. https://doi.org/10.1007/978-1-4757-4552-8_7
908. Trill, M. D. (2013). Anxiety and sleep disorders in cancer patients. European Journal of Cancer Supplements. https://doi.org/10.1016/j.ejcsup.2013.07.009
909. Trivedi, K., Kataria, L., & Patel, D. (2020). A COMPARATIVE STUDY EVALUATING THE DEPRESSIVE SYMPTOMS AND FUNCTIONAL OUTCOME IN PATIENTS TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS V/S SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS AS ANTIDEPRESSANT AGENTS IN MAJOR DEPRESSIVE DISORDER.
910. Trzepacz, P. T. (1999). Update on the Neuropathogenesis of Delirium. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000017164
911. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
912. Tune, L. E. (1998). Depression and Alzheimer's disease. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(1998)8:1+<91::aid-da14>3.0.co;2-m
913. Tuulio‐Henriksson, A. (2014). [Cognitive functions in severe psychotic disorders].. PubMed.
914. Túry, F., & Kovács-Tóth, B. (2019). [The role of traumatization in eating disorders. Possible therapeutic modalities with special regard to cognitive behavioural methods].. PubMed.
915. Uehara, T., Ishige, Y., & Su, M. (2011). Dissociative Tendency, Anger Expression, and Frontal Activation During a Verbal Fluency Task. InTech eBooks. https://doi.org/10.5772/26312
916. Uhlmann, C., Widmann, B., & Baier, H. (2011). Erfassung kognitiver Defizite bei Patienten mit Intelligenzminderung und Epilepsie. Aktuelle Neurologie. https://doi.org/10.1055/s-0030-1266064
917. Urazán, D. T., Barragán, A. G., Hernández, K. D. C. P., & Gamboa, D. J. (2023). Afasia primaria progresiva variante no fluente/agramática. Acta neurológica colombiana. https://doi.org/10.22379/anc.v39i3.853
918. Valdéz, P. (2018). Homeostatic and circadian regulation of cognitive performance. Biological Rhythm Research. https://doi.org/10.1080/09291016.2018.1491271
919. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
920. Vance, D. E. (2012). Potential factors that may promote successful cognitive aging. Nursing Research and Reviews. https://doi.org/10.2147/nrr.s32229
921. Vance, D. E., Eaves, Y. D., Keltner, N. L., & Struzick, T. S. (2010). Practical Implications of Procedural and Emotional Religious Activity Therapy for Nursing. Journal of Gerontological Nursing. https://doi.org/10.3928/00989134-20100303-04
922. Vanhaudenhuyse, A. (2012). The neural correlates of conscious awareness revealed by the study of coma and related states.
923. Vasilijević, S., Vuković, M., & Jerkić, L. (2021). COGNITIVE AND LANGUAGE DEFICITS IN VASCULAR DEMENTIA. Acta Medica Medianae. https://doi.org/10.5633/amm.2021.0312
924. Vasilyeva, Y. B. (2019). Clinical Features of Traumatic Brain Injury in Various Kinds of Brain Damage. Russian Sklifosovsky Journal Emergency Medical Care. https://doi.org/10.23934/2223-9022-2019-8-3-295-301
925. Vasquez-Baiocchi, M. A. J., & Burneo, J. G. (2021). Epilepsias mioclónicas progresivas. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v83i4.3891
926. Verstraeten, E., Cluydts, R., Verbraecken, J., & Roeck, J. D. (1996). Neuropsychological functioning and determinants of morning alertness in patients with obstructive sleep apnea syndrome. Journal of the International Neuropsychological Society. https://doi.org/10.1017/s1355617700001326
927. Vijayan, V., Govind, K., & Raju, R. (2018). Managing ADHD with Nutrition – A Case Study Report. International Journal of Indian Psychology. https://doi.org/10.25215/0602.030
928. Vingerhoets, W., Bloemen, O., Bakker, G., & Amelsvoort, T. V. (2013). Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2013.00157
929. Vohs, J. L., George, S., Leonhardt, B. L., & Lysaker, P. H. (2016). An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments.
930. Vohs, J. L., George, S., Leonhardt, B. L., & Lysaker, P. H. (2016). An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2016.1199275
931. Volel, B. A., Petelin, D. S., & Malyutina, A. A. (2018). Cognitive impairment in anxiety disorders. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2018-1-78-82
932. Volpe, B. T. (1997). Delayed Neuronal Degeneration Results from Endogenous Glutamate Excess. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48390.x
933. Vuilleumier, P., Vocat, R., & Saj̈, A. (2013). Denial of Illness. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-1-4471-2428-3_9
934. Wade, D. T. (2024). Prolonged disorder of consciousness: giving a second opinion on the best interests of a person. Practical Neurology. https://doi.org/10.1136/pn-2024-004273
935. Wahyuni, A., & Berawi, K. (2016). Pengaruh Aktivitas dan Latihan Fisik terhadap Fungsi Kognitif pada Penderita Demensia. Jurnal Majority.
936. Waite, J., Harwood, R., Morton, I., & Connelly, D. (2008). What is dementia?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199228829.003.0001
937. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
938. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
939. Waldstein, S. R. (2003). The Relation of Hypertension to Cognitive Function. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.01212
940. Walker, J. S., & Abou‐Khalil, B. (2009). Seizures: Behavioral. Wiley Encyclopedia of Forensic Science. https://doi.org/10.1002/9780470061589.fsa507
941. Walker, W. O., & Johnson, C. P. (2006). Mental Retardation. Pediatrics in Review. https://doi.org/10.1542/pir.27.6.204
942. Wallner, R., Senczyszyn, A., Budrewićz, S., & Rymaszewska, J. (2019). Zaburzenia poznawcze i neuropsychiatryczne w chorobie Parkinsona. Polski Przegląd Neurologiczny. https://doi.org/10.5603/ppn.2019.0018
943. Wang, Y., & Salas, R. M. E. (2021). Approach to Common Sleep Disorders. Seminars in Neurology. https://doi.org/10.1055/s-0041-1726364
944. Watkins, C. V., & Peñailillo, B. V. (2004). Efectividad de un modelo de psicoterapia grupal desde la perspectiva constructivista - evolutiva en niños con trastorno de déficit atencional subtipo hiperactivo - impulsivo.
945. Weinberger, D. R., & Gallhofer, B. (1997). Cognitive function in schizophrenia. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199709004-00006
946. Weinshenker, B. G., & Mowzoon, N. (2006). Acute Treatments. CRC Press eBooks. https://doi.org/10.3109/9781420018714-15
947. Weller, R. O., Swash, M., McLellan, D. L., & Scholtz, C. L. (1983). Dementia. Clinical Neuropathology. https://doi.org/10.1007/978-1-4471-1335-5_15
948. Weller, R. O., Swash, M., McLellan, D. L., & Scholtz, C. L. (1983). The Interpretation of Neurological Symptoms and Signs. Clinical Neuropathology. https://doi.org/10.1007/978-1-4471-1335-5_3
949. Welsh‐Bohmer, K. A., Attix, D. K., & Mason, D. J. (2020). The Clinical Utility of Neuropsychological Evaluation of Patients with Known or Suspected Dementia. Psychology Press eBooks. https://doi.org/10.4324/9781315787039-13
950. Werf-Eldering, M. J. V. D., Schouws, S., Arts, B., & Jabben, N. (2012). [Cognitive dysfunction in bipolar disorder: determinants and functional outcome].. PubMed.
951. Werth, R. (2018). Rapid improvement of reading performance in children with dyslexia by altering the reading strategy: A novel approach to diagnoses and therapy of reading deficiencies. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-180829
952. Westby, A., & Coburn-Pierce, M. (2018). Autism spectrum disorder in primary care. The Nurse Practitioner. https://doi.org/10.1097/01.npr.0000530326.85465.8b
953. Weyer, K. (2017). Demenz – eine diagnostische und therapeutische Herausforderung. Phlebologie.
954. Wheeler, S. (2014). Approaches to Managing Executive Cognitive Functioning Impairment Following TBI: A Focus on Facilitating Community Participation. InTech eBooks. https://doi.org/10.5772/57395
955. Whitaker, S. (2018). Intellectual disability: An inability to cope with the real world (not an inability to cope with IQ tests).
956. wicaksono, D. P., & Muhlisin, S. H. A. (2015). Asuhan Keperawatan Keluarga Tn.T Khususnya Ny.M Dengan Gangguan Sistem Persarafan: Stroke Non Hemoragik Di DesaJagalan Rt 01 Rw 07 Pabelan Kartasura Wilayah Kerja Puskesmas Kartasura.
957. Wiebe, D. J., Comstock, R. D., & Nance, M. L. (2011). Concussion research: a public health priority. Injury Prevention. https://doi.org/10.1136/ip.2010.031211
958. Wierenga, C. E., & Bondi, M. W. (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations.
959. Willroth, E. C., James, B. D., Graham, E. K., Kapasi, A., Bennett, D. A., & Mroczek, D. K. (2022). Well-being and Cognitive Resilience to Dementia-related Neuropathology. https://doi.org/10.31234/osf.io/sbh85
960. Wilson, D. S., & Nutt, P. D. J. (2013). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199674558.003.0003
961. Winkelman, J. W. (2009). The Diagnosis and Work-Up of Insomnia. CNS Spectrums. https://doi.org/10.1017/s1092852900003941
962. Winter, A., & Buhlmann, U. (2013). Spieglein, Spieglein an der Wand … Klinische Charakteristika der körperdysmorphen Störung. Zeitschrift für Psychiatrie Psychologie und Psychotherapie. https://doi.org/10.1024/1661-4747/a000155
963. Wolkorte, R., Heersema, D., & Zijdewind, I. (2014). Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue. Neurorehabilitation and neural repair. https://doi.org/10.1177/1545968314552529
964. Wong, S. Y., & Yeo, K. J. (2014). Positive outcome with neurofeedback treatment in a case of child with mild Autism Spectrum Disorder.
965. Wortzel, H. S., Brenner, L. A., & Silver, J. (2018). Traumatic Brain Injury. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy12
966. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
967. Xie, C., Chen, P., & Liang, S. (2012). The Role of Blue Native/ SDS PAGE in Depression Research. InTech eBooks. https://doi.org/10.5772/33351
968. Yadav, S. (2019). A Study to Assess Effectiveness of Structured Teaching Programme (STP) on Knowledge Regarding Dementia among Adults in A Selected Community Area at Delhi NCR. International Journal of Research.
969. Yamauchi, T. (1998). Impairment of Consciousness During Epileptic Seizures with Special Reference to Neuronal Mechanisms. Epilepsia. https://doi.org/10.1111/j.1528-1157.1998.tb05144.x
970. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
971. Yang, G. (2004). From sensor networks to behaviour profiling: a homecare perspective of intelligent buildings. https://doi.org/10.1049/ic:20040639
972. YILMAZ, D. A. (2021). Sedanter davranış ve bilişsel fonksiyon. Maltepe Tıp Dergisi. https://doi.org/10.35514/mtd.2021.52
973. Yorozuya, K., Kubo, Y., ASAOKA, Y., Hayashi, H., Fujita, T., & Hanaoka, H. (2024). A multimodal non‐pharmacological intervention for persons with dementia in nursing homes: a multicentre randomised controlled trial. Psychogeriatrics. https://doi.org/10.1111/psyg.13186
974. Young, J., Meagher, D., & MacLullich, A. M. J. (2011). Cognitive assessment of older people. BMJ. https://doi.org/10.1136/bmj.d5042
975. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
976. Zalonis, I., Christidi, F., Kararizou, E., Triantafyllou, N., Spengos, K., & Vassilopoulos, D. (2010). Cognitive Deficits Presenting as Psychiatric Symptoms in a Patient with Moyamoya Disease. Psychological Reports. https://doi.org/10.2466/02.13.15.22.pr0.107.6.727-732
977. Zamorski, M. A., & Ward, R. (2000). Social Anxiety Disorder: Common, Disabling, and Treatable. The Journal of the American Board of Family Medicine. https://doi.org/10.3122/15572625-13-4-251
978. Zavadlav, M. (2015). Zdravstvena njega bolesnika sa moždanim udarom.
979. Zemla, J. C. (2024). Increased reliance on heuristic thinking in mild cognitive impairment. Aging Neuropsychology and Cognition. https://doi.org/10.1080/13825585.2024.2405506
980. Zengaffinen, F. S., Stahnke, A., Furger, S., Dierks, T., Federspiel, A., Hatzinger, M., König, T., Nick, B., Rapp, C., Stegmayer, K., Strik, W., Walther, S., Wiest, R., & Papmeyer, M. (2017). Jumping to Associations during Psychosis.
981. Zhao, H., Wang, Y., Cui, L., Wang, H., Liu, S., Liang, T., Liu, D., Qiu, J., Chen, L., & Sun, Y. (2024). Sensorineural hearing loss and cognitive impairment: three hypotheses. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2024.1368232
982. Zhao, J., & Tomm, B. M. (2016). Psychological Responses to Scarcity. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.41
983. Zhao, S., Scholcz, A., Rouse, M. A., Klar, V., Ganse‐Dumrath, A., Toniolo, S., Broulidakis, M. J., Ralph, M. A. L., Rowe, J. B., Garrard, P., Thompson, S., Irani, S. R., Manohar, S., & Husain, M. (2025). Self- versus caregiver-reported apathy across neurological disorders. Brain Communications. https://doi.org/10.1093/braincomms/fcaf235
984. Zhao, Z., Wu, H., & Huang, L. (2007). Clinical diagnosis and assessment of insomnia. Chinese Journal of New Drugs and Clinical Remedies.
985. Zhban, E. S., Likhanov, M., Zakharov, I., Bezrukova, E. M., & Malykh, S. (2018). The Role of Mathematical and Trait Anxiety in Mental Fatigue: an EEG Investigation. Psychology in Russia State of Art. https://doi.org/10.11621/pir.2018.0406
986. Zhurkova, N. V., Volgina, S. Y., Gamirova, R., & Solovyeva, N. A. (2022). Early diagnostics of motor disorders in children: an interdisciplinary approach. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). https://doi.org/10.21508/1027-4065-2022-67-5-225-230
987. Zike, T., Crowder, J. J., & Pederson, B. A. (2019). Physiological Responses to Hypoxia in the Absence of Brain Glycogen. Proceedings of IMPRS. https://doi.org/10.18060/23639
988. Zupan-Simunek, V. (2012). [Neurological consequences of prematurity].. PubMed.
989. Zúñiga, R. L. (2017). Delirium y la presencia de respuesta inflamatoria sistémica, descontrol glucémico e hipoxia en pacientes mayores de 65 años en el servicio de urgencias médicas del Hospital General de Pachuca..
990. Češková, E., & Kučerová, H. P. (2018). Kognitivní dysfunkce u deprese.
991. Şenel, G. B., & Karadeniz, D. (2022). Neuroanatomical and Etiological Approaches to Secondary Narcolepsy. Neurological Sciences and Neurophysiology. https://doi.org/10.4103/nsn.nsn_5_22
992. Šumarac-Dumanović, M., Micić, D., Macut, Đ. P., Kendereški, A., Zorić, S., Cvijović, G., & Pejković, D. (2002). Hipoglikemijski sindromi - dijagnostički i terapijski pristup i prikaz dva slučaja. ABC - časopis urgentne medicine.